<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="0dd76a51-ec90-426c-8442-4e0a53024a30"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA.<br/>
      <br/>BYETTAÂ® (exenatide) injection, for subcutaneous use<br/>Initial U.S. Approval: 2005</title>
   <effectiveTime value="20250528"/>
   <setId root="53d03c03-ebf7-418d-88a8-533eabd2ee4f"/>
   <versionNumber value="25"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="054743190" root="1.3.6.1.4.1.519.1"/>
            <name>AstraZeneca Pharmaceuticals LP</name>
            <assignedEntity>
               <assignedOrganization>
                  <id extension="230790719" root="1.3.6.1.4.1.519.1"/>
                  <name>AstraZeneca PLC</name>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="bcfa6997-f9dc-4f3f-ad22-99cbb0d9f53d"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20241101"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0310-6512" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Byetta</name>
                        <formCode code="C42946" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>exenatide</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="ug" value="250"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="9P1872D4OL" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>exenatide</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="9P1872D4OL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>exenatide</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="Q40Q9N063P" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>acetic acid</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>mannitol</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value="2.2"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="GGO4Y809LO" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>metacresol</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="4550K0SC9B" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>sodium acetate</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>water</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="1.2"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0310-6512-01" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="completed"/>
                                       <effectiveTime>
                                          <low value="20141210"/>
                                          <high value="20261231"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102835" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="1.2"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0310-6512-85" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="completed"/>
                                       <effectiveTime>
                                          <low value="20150615"/>
                                          <high value="20190131"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102835" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA021773" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="completed"/>
                           <effectiveTime>
                              <low value="20141210"/>
                              <high value="20261231"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0310-6524" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Byetta</name>
                        <formCode code="C42946" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>exenatide</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="ug" value="250"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="9P1872D4OL" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>exenatide</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="9P1872D4OL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>exenatide</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="Q40Q9N063P" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>acetic acid</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>mannitol</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value="2.2"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="GGO4Y809LO" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>metacresol</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="4550K0SC9B" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>sodium acetate</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>water</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="2.4"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43183" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTRIDGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0310-6524-01" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="completed"/>
                                       <effectiveTime>
                                          <low value="20141212"/>
                                          <high value="20261130"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102835" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA021773" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="completed"/>
                           <effectiveTime>
                              <low value="20141212"/>
                              <high value="20261130"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="ID_F319551C-A293-4402-9369-EAD976A66494">
               <id root="e107a5b3-c417-4582-87bc-028bcf8f89f4"/>
               <code code="43683-2" codeSystem="2.16.840.1.113883.6.1" displayName="RECENT MAJOR CHANGES SECTION"/>
               <effectiveTime value="20241101"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph/>
                        <paragraph>Warnings and Precautions, Pulmonary Aspiration During General Anesthesia or Deep Sedation (<linkHtml href="#ID_bf76a419-898f-457f-9de6-018ca84f6012">5.10</linkHtml>)	11/2024</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S1">
               <id root="7edeb294-459d-465e-9529-98c0fbff4d4b"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.</paragraph>
                  <paragraph>
                     <content styleCode="underline">Limitations of Use</content>
                  </paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>
                        <content styleCode="xmChange">BYETTA contains exenatide. Coadministration with other exenatide-containing products is not recommended. </content>
                     </item>
                  </list>
               </text>
               <effectiveTime value="20250528"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>BYETTA (exenatide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (<linkHtml href="#S1">1</linkHtml>, <linkHtml href="#ID_00eafa89-0751-4a85-a506-88a98705f88c">14</linkHtml>)</paragraph>
                        <paragraph>
                           <content styleCode="underline">Limitations of Use</content>
                        </paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>Coadministration with other exenatide-containing products is not recommended (<linkHtml href="#S1">1</linkHtml>).</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S2">
               <id root="a55655b8-1a5e-45ff-8b9f-9634ca7568e5"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION</title>
               <effectiveTime value="20250528"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>Inject subcutaneously within 60 minutes prior to morning and evening meals (or before the two main meals of the day, approximately 6 hours or more apart). (<linkHtml href="#S2.1">2.1</linkHtml>) </item>
                           <item>
                              <caption>â¢</caption>Initiate at 5 mcg per dose twice daily; increase to 10 mcg twice daily after 1 month based on clinical response. (<linkHtml href="#S2.1">2.1</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="S2.1">
                     <id root="f1a8bac3-8d00-4c36-8d51-f67a95cb97f7"/>
                     <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
                     <title>2.1 Recommended Dosing</title>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>Initiate BYETTA at 5 mcg administered subcutaneously twice daily at any time within the 60-minute period before the morning and evening meals (or before the two main meals of the day, approximately 6 hours or more apart). Do not administer after a meal.</item>
                           <item>
                              <caption>â¢</caption>Based on clinical response, the dose of BYETTA can be increased to 10 mcg twice daily which is recommended after 1 month of therapy, in order to reduce the risk of gastrointestinal adverse reactions <content styleCode="italics">[see <linkHtml href="#S5.5">Warnings and Precautions (5.5)</linkHtml> and <linkHtml href="#ID_161f05fe-ae09-4458-ac9f-42c2b3104e4a">Adverse Reactions (6.1)</linkHtml>]</content>.</item>
                           <item>
                              <caption>â¢</caption>Administer as a subcutaneous injection in the thigh, abdomen, or upper arm. </item>
                           <item>
                              <caption>â¢</caption>Rotate injections sites with each dose. Do not use the same site for each injection.</item>
                           <item>
                              <caption>â¢</caption>Inspect visually for particulate matter and discoloration. Only use BYETTA if the solution appears clear, colorless, and contains no particles.</item>
                           <item>
                              <caption>â¢</caption>When using BYETTA with insulin, administer as separate injections and never mix. It is acceptable to inject BYETTA and insulin in the same body region, but the injections should not be adjacent to each other.</item>
                           <item>
                              <caption>â¢</caption>If a dose is missed, resume the treatment regimen as prescribed with the next scheduled dose.</item>
                        </list>
                     </text>
                     <effectiveTime value="20250528"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S3">
               <id root="84a6a0c5-b469-49b2-833c-13a949caff2e"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS</title>
               <text>
                  <paragraph>BYETTA injection is a clear, colorless solution of 250 mcg/mL exenatide supplied as follows:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>5 mcg per dose in a 1.2 mL single-patient-use prefilled pen (60 doses)</item>
                     <item>
                        <caption>â¢</caption>10 mcg per dose in a 2.4 mL single-patient-use prefilled pen (60 doses)</item>
                  </list>
               </text>
               <effectiveTime value="20221221"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>BYETTA injection is supplied as 250 mcg/mL exenatide in:</paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>5 mcg per dose, 60 doses, 1.2 mL single-patient-use prefilled pen</item>
                           <item>
                              <caption>â¢</caption>10 mcg per dose, 60 doses, 2.4 mL single-patient-use prefilled pen</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S4">
               <id root="fc9cc34d-b762-47d6-995c-8c5f9ce429d8"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS</title>
               <text>
                  <paragraph>BYETTA is contraindicated in patients with:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>A prior severe hypersensitivity reaction to exenatide or to any of the excipients in BYETTA. Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported with BYETTA <content styleCode="italics">[see <linkHtml href="#S5.7">Warnings and Precautions (5.7)</linkHtml>].</content>
                     </item>
                     <item>
                        <caption>â¢</caption>A history of drug-induced immune-mediated thrombocytopenia from exenatide products. Serious bleeding, which may be fatal, from drug-induced immune-mediated thrombocytopenia has been reported with exenatide use <content styleCode="italics">[see <linkHtml href="#S5.8">Warnings and Precautions (5.8)</linkHtml>]</content>.</item>
                  </list>
               </text>
               <effectiveTime value="20221221"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>History of severe hypersensitivity to exenatide or any of the excipients in BYETTA. <linkHtml href="#S4">(4)</linkHtml>
                           </item>
                           <item>
                              <caption>â¢</caption>History of drug-induced immune-mediated thrombocytopenia from exenatide products. (<linkHtml href="#S4">4</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="S5">
               <id root="524e9ce0-63ae-4cc2-ae63-dc303b83f42f"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5 WARNINGS AND PRECAUTIONS</title>
               <effectiveTime value="20250528"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Acute Pancreatitis</content>: Has been observed in patients treated with GLP-1 receptor agonists, including BYETTA. Discontinue if pancreatitis is suspected. (<linkHtml href="#S5.1">5.1</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Never share</content> a BYETTA pen between patients, even if the needle is changed. (<linkHtml href="#S5.2">5.2</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin:</content> Patients taking an insulin secretagogue or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia. Reduction in the dose of insulin secretagogues or insulin may be necessary. (<linkHtml href="#S5.3">5.3</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Acute Kidney Injury Due to Volume Depletion</content>: Monitor renal function in patients reporting adverse reactions that could lead to volume depletion (<linkHtml href="#S5.4">5.4</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Severe Gastrointestinal Adverse Reactions</content>: Use has been associated with gastrointestinal adverse reactions, sometimes severe. BYETTA is not recommended in patients with severe gastroparesis. (<linkHtml href="#S5.5">5.5</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Immunogenicity:</content> Patients may develop antibodies to exenatide. If there is worsening glycemic control or failure to achieve target glycemic control, consider alternative antidiabetic therapy. (<linkHtml href="#S5.6">5.6</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Hypersensitivity:</content> Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue BYETTA and promptly seek medical advice. (<linkHtml href="#S5.7">5.7</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Drug-induced Immune-mediated Thrombocytopenia:</content> Serious bleeding which may be fatal has been reported. Discontinue BYETTA promptly and avoid re-exposure to exenatide. (<linkHtml href="#S5.8">5.8</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Acute Gallbladder Disease:</content> If cholelithiasis or cholecystitis are suspected, gallbladder studies are indicated. (<linkHtml href="#ID_b2273663-5dc6-4684-8c17-62f4a2521929">5.9</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>
                              <content styleCode="underline">Pulmonary Aspiration During General Anesthesia or Deep Sedation:</content> Has been reported in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures. Instruct patients to inform healthcare providers of any planned surgeries or procedures. (<linkHtml href="#ID_bf76a419-898f-457f-9de6-018ca84f6012">5.10</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="S5.1">
                     <id root="9d2c1140-aef9-4f60-b1da-33bfe25cb04f"/>
                     <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
                     <title>5.1 Acute Pancreatitis</title>
                     <text>
                        <paragraph>Acute pancreatitis, including fatal and non-fatal hemorrhagic or  necrotizing pancreatitis, has been observed in patients treated with glucagon-like peptide-1 (GLP-1) receptor agonists, including BYETTA <content styleCode="italics">[see <linkHtml href="#ID_652bcd3d-50eb-4f98-84d7-d93344de1107">Adverse Reactions (6.2)</linkHtml>]</content>. After initiation of BYETTA, observe patients carefully for signs and symptoms of pancreatitis (including persistent severe abdominal pain, sometimes radiating to the back and which may or may not be accompanied by vomiting). If pancreatitis is suspected, discontinue BYETTA and initiate appropriate management.</paragraph>
                     </text>
                     <effectiveTime value="20250528"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.2">
                     <id root="470589e7-8656-42ee-8988-98c564f2e612"/>
                     <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
                     <title>5.2 Never Share a BYETTA Pen Between Patients</title>
                     <text>
                        <paragraph>BYETTA pens must never be shared between patients, even if the needle is changed. Pen-sharing poses a risk for transmission of blood-borne pathogens.</paragraph>
                     </text>
                     <effectiveTime value="20250528"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.3">
                     <id root="3f0448d1-7a69-4d5b-a695-6dcb191323de"/>
                     <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
                     <title>5.3 Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin</title>
                     <text>
                        <paragraph>Patients receiving BYETTA in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia including severe hypoglycemia <content styleCode="italics">[see </content>
                           <content styleCode="italics">
                              <linkHtml href="#S6">Adverse Reactions (6)</linkHtml>
                           </content>
                           <content styleCode="italics"> and <linkHtml href="#S7">Drug Interactions (7)</linkHtml>]</content>.</paragraph>
                        <paragraph>The risk of hypoglycemia may be lowered by a reduction in the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Inform patients using these concomitant medications of the risk of hypoglycemia and educate them on the signs and symptoms of hypoglycemia. </paragraph>
                     </text>
                     <effectiveTime value="20250528"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.4">
                     <id root="38f3fcde-887e-4d84-b380-c2d6165770d6"/>
                     <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
                     <title>5.4 Acute Kidney Injury Due to Volume Depletion</title>
                     <text>
                        <paragraph>There have been postmarketing reports of acute kidney injury, in some cases requiring hemodialysis, in patients treated with GLP-1 receptor agonists, BYETTA <content styleCode="italics">[see <linkHtml href="#ID_652bcd3d-50eb-4f98-84d7-d93344de1107">Adverse Reactions (6.2)</linkHtml>]</content>. The majority of the reported events occurred in patients who experienced gastrointestinal reactions leading to dehydration such as nausea, vomiting, or diarrhea <content styleCode="italics">[see <linkHtml href="#S6">Adverse Reactions (6)</linkHtml>]</content>. Monitor renal function in patients reporting adverse reactions to BYETTA that could lead to volume depletion, especially during dosage initiation and escalation of BYETTA.</paragraph>
                        <paragraph>BYETTA is not recommended in patients with severe renal impairment (creatinine clearance &lt;30 mL/min) or end-stage renal disease and should be used with caution in patients with renal transplantation <content styleCode="italics">[see <linkHtml href="#S8.6">Use in Specific Populations (8.6)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20250528"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.5">
                     <id root="cc1f551a-f73b-4c35-ae79-09985e02e258"/>
                     <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
                     <title>5.5 Severe Gastrointestinal Adverse Reactions</title>
                     <text>
                        <paragraph>Use of GLP-1 receptor agonists, including BYETTA, has been associated with gastrointestinal adverse reactions, sometimes severe <content styleCode="italics">[see <linkHtml href="#S6">Adverse Reactions (6)</linkHtml>]</content>. BYETTA is not recommended in patients with severe gastroparesis.</paragraph>
                     </text>
                     <effectiveTime value="20250528"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.6">
                     <id root="46acde06-7208-48b6-a275-081762607933"/>
                     <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
                     <title>5.6 Immunogenicity</title>
                     <text>
                        <paragraph>Patients may develop antibodies to exenatide following treatment with BYETTA. Antibody levels were measured in 90% of subjects in the 30-week, 24-week, and 16-week placebo-controlled studies and the 30-week comparator-controlled study of BYETTA. In 3%, 4%, 1%, and 1% of these patients, respectively, antibody formation was associated with an attenuated glycemic response. If there is worsening glycemic control or failure to achieve targeted glycemic control, alternative antidiabetic therapy should be considered <content styleCode="italics">[see<linkHtml href="#_RefS6.1"> Adverse Reactions (6.1)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20181221"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.7">
                     <id root="f3c3efc9-3801-447e-bfe6-e1606a84f394"/>
                     <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
                     <title>5.7 Hypersensitivity</title>
                     <text>
                        <paragraph>There have been postmarketing reports of serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) in patients treated with BYETTA. If a hypersensitivity reaction occurs, the patient should discontinue BYETTA and other suspect medications and promptly seek medical advice. Inform and closely monitor patients with a history of anaphylaxis or angioedema with another GLP-1 receptor agonist for allergic reactions, because it is unknown whether such patients will be predisposed to anaphylaxis with BYETTA <content styleCode="italics">[see<linkHtml href="#_RefS6.2"> Adverse Reactions (6.2)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20221221"/>
                  </section>
               </component>
               <component>
                  <section ID="S5.8">
                     <id root="daa68841-985a-4f8e-bcc1-94b0a0920e49"/>
                     <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
                     <title>5.8 Drug-Induced Thrombocytopenia</title>
                     <text>
                        <paragraph>Serious bleeding, which may be fatal, from drug-induced immune-mediated thrombocytopenia has been reported in the postmarketing setting with exenatide use. Drug-induced thrombocytopenia is an immune-mediated reaction, with exenatide-dependent anti-platelet antibodies. In the presence of exenatide, these antibodies cause platelet destruction. If drug-induced thrombocytopenia is suspected, discontinue BYETTA immediately and do not re-expose the patient to exenatide <content styleCode="italics">[see <linkHtml href="#ID_652bcd3d-50eb-4f98-84d7-d93344de1107">Adverse Reactions (6.2)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20221221"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_b2273663-5dc6-4684-8c17-62f4a2521929">
                     <id root="4e9542bb-299d-4aa4-8c2e-34a821361481"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.9 Acute Gallbladder Disease </title>
                     <text>
                        <paragraph>Acute events of gallbladder disease such as cholelithiasis or cholecystitis have been reported in GLP-1 receptor agonist trials and postmarketing. In a clinical study with exenatide, 1.9% of exenatide-treated patients and 1.4% of placebo-treated patients reported an acute event of gallbladder disease, such as cholelithiasis or cholecystitis. If cholelithiasis is suspected, gallbladder studies and appropriate clinical follow-up are indicated.</paragraph>
                     </text>
                     <effectiveTime value="20221221"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_bf76a419-898f-457f-9de6-018ca84f6012">
                     <id root="9bbd61f4-3c10-45dd-8eea-84a23da2cc94"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>
                        <content styleCode="xmChange">5.10 Pulmonary Aspiration During General Anesthesia or Deep Sedation</content>
                     </title>
                     <text>
                        <paragraph>
                           <content styleCode="xmChange">BYETTA delays gastric emptying [<content styleCode="italics">see </content>
                           </content>
                           <content styleCode="italics">
                              <linkHtml href="#S12.2">Clinical Pharmacology (12.2)</linkHtml>
                           </content>
                           <content styleCode="xmChange">]. There have been rare postmarketing reports of pulmonary aspiration in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation who had residual gastric contents despite reported adherence to preoperative fasting recommendations. </content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="xmChange">Available data are insufficient to inform recommendations to mitigate the risk of pulmonary aspiration during general anesthesia or deep sedation in patients taking BYETTA, including whether modifying preoperative fasting recommendations or temporarily discontinuing BYETTA could reduce the incidence of retained gastric contents. Instruct patients to inform healthcare providers prior to any planned surgeries or procedures if they are taking BYETTA.</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20250528"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S6">
               <id root="e1c2b9bf-5910-4153-b66a-6b3447e2e827"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS</title>
               <text>
                  <paragraph>The following serious adverse reactions are described below or elsewhere in the prescribing information:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>â¢</caption>Acute Pancreatitis <content styleCode="italics">[see <linkHtml href="#S5.1">Warnings and Precautions (5.1)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Never Share a BYETTA Pen Between Patients <content styleCode="italics">[see <linkHtml href="#S5.2">Warnings and Precautions (5.2)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin <content styleCode="italics">[see <linkHtml href="#S5.3">Warnings and Precautions (5.3)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Acute Kidney Injury Due to Volume Depletion <content styleCode="italics">[see <linkHtml href="#S5.4">Warnings and Precautions (5.4)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Severe Gastrointestinal Adverse Reactions <content styleCode="italics">[see <linkHtml href="#S5.5">Warnings and Precautions (5.5)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Immunogenicity <content styleCode="italics">[see <linkHtml href="#S5.6">Warnings and Precautions (5.6)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Hypersensitivity <content styleCode="italics">[see <linkHtml href="#S5.7">Warnings and Precautions (5.7)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Drug-Induced Thrombocytopenia <content styleCode="italics">[see <linkHtml href="#S5.8">Warnings and Precautions (5.8)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Acute Gallbladder Disease <content styleCode="italics">[see <linkHtml href="#ID_b2273663-5dc6-4684-8c17-62f4a2521929">Warnings and Precautions (5.9)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>â¢</caption>Pulmonary Aspiration During General Anesthesia or Deep Sedation <content styleCode="italics">[see <linkHtml href="#ID_bf76a419-898f-457f-9de6-018ca84f6012">Warnings and Precautions (5.10)</linkHtml>]</content>
                     </item>
                  </list>
               </text>
               <effectiveTime value="20250528"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>Most common (â¥5%) and occurring more frequently than placebo in clinical trials: nausea, hypoglycemia, vomiting, diarrhea, feeling jittery, dizziness, headache, dyspepsia, constipation, asthenia. Nausea usually decreases over time. (<linkHtml href="#S5.3">5.3</linkHtml>,<linkHtml href="#S6"> 6</linkHtml>)</item>
                        </list>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact AstraZeneca at 1-800-236-9933 or FDA at 1-800-FDA-1088 or <linkHtml href="http://www.fda.gov/medwatch">www.fda.gov/medwatch</linkHtml>.</content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_161f05fe-ae09-4458-ac9f-42c2b3104e4a">
                     <id root="e2bafcff-9ba6-49bd-9734-a35215c68e2c"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>6.1 Clinical Trial Experience </title>
                     <text>
                        <paragraph>Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.</paragraph>
                        <paragraph>
                           <content styleCode="bold">Hypoglycemia</content>
                        </paragraph>
                        <paragraph>Table 1 summarizes the incidence and rate of hypoglycemia with BYETTA in six placebo-controlled clinical trials.</paragraph>
                        <table cellpadding="5.75pt" width="100%">
                           <caption>Table 1: Incidence (%) and Rate of Hypoglycemia when BYETTA was used as Monotherapy or with Concomitant Antidiabetic Therapy in Six Placebo-Controlled Clinical Trials<footnote ID="_Ref534175088">A hypoglycemic episode was recorded if a patient reported symptoms of hypoglycemia with or without a blood glucose value consistent with hypoglycemia. Severe hypoglycemia was defined as an event with symptoms consistent with hypoglycemia requiring the assistance of another person and associated with either a documented blood glucose value &lt;54 mg/dL or prompt recovery after treatment for hypoglycemia.</footnote>
                           </caption>
                           <col width="44%"/>
                           <col width="14%"/>
                           <col width="21%"/>
                           <col width="20%"/>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top"/>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Placebo</content>
                                       <br/>
                                       <content styleCode="bold">BID</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">BYETTA</content>
                                       <br/>
                                       <content styleCode="bold">5 mcg BID</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">BYETTA</content>
                                       <br/>
                                       <content styleCode="bold">10 mcg BID</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Monotherapy (24 Weeks)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â N</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>77</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>77</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>78</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Overall</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1.3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5.2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3.8%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Rate (episodes/patient-year)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.03</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.21</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.52</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Severe</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">With Metformin (30 Weeks)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â N</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>113</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>110</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>113</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Overall</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5.3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4.5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5.3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Rate (episodes/patient-year)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.12</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.13</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.12</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Severe</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">With a Sulfonylurea (30 Weeks)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â N</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>123</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>125</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>129</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Overall</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3.3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>14.4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>35.7%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Rate (episodes/patient-year)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.07</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.64</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1.61</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Severe</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">With Metformin and a Sulfonylurea (30 Weeks)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â N</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>247</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>245</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>241</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Overall</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>12.6%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>19.2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>27.8%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Rate (episodes/patient-year)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.58</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.78</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1.71</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Severe</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">With a Thiazolidinedione (16 Weeks)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â N</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>112</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>not evaluated</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>121</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Overall</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7.1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>not evaluated</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>10.7%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Rate (episodes/patient-years)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.56</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>not evaluated</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.98</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Severe</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>not evaluated</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">With Insulin Glargine with or without Metformin and/or Thiazolidinedione (30 Weeks)</content>
                                       <footnote ID="_Ref534175284">When BYETTA was initiated in combination with insulin glargine, the dose of insulin glargine was decreased by 20% in patients with an HbA<sub>1c</sub> â¤8.0% to minimize the risk of hypoglycemia. See Table 9 for insulin dose titration algorithm.</footnote>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â N</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>122</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>not evaluated</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>137</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Overall</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>29.5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>not evaluated</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>24.8%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Rate (episodes/patient-years)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1.58</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>not evaluated</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1.61</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â % Severe</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.8%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>not evaluated</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.0%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Toprule " valign="top">
                                    <paragraph>N = number of Intent-to-Treat subjects in each treatment group.</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>
                           <content styleCode="bold">Immunogenicity</content>
                        </paragraph>
                        <paragraph>Antibodies were assessed in 90% of subjects in the 30-week, 24-week, and 16-week studies of BYETTA. In the 30-week controlled trials of BYETTA add-on to metformin and/or sulfonylurea, antibodies were assessed at 2- to 6-week intervals. The mean antibody titer peaked at Week 6 and was reduced by 55% by Week 30. Three hundred and sixty patients (38%) had low titer antibodies (&lt;625) to exenatide at 30 weeks. The level of glycemic control (HbA<sub>1c</sub>) in these patients was generally comparable to that observed in the 534 patients (56%) without antibody titers. An additional 59 patients (6%) had higher titer antibodies (â¥625) at 30 weeks. Of these patients, 32 (3% overall) had an attenuated glycemic response to BYETTA; the remaining 27 (3% overall) had a glycemic response comparable to that of patients without antibodies.</paragraph>
                        <paragraph>In the 16-week trial of BYETTA add-on to thiazolidinediones, with or without metformin, 36 patients (31%) had low titer antibodies to exenatide at 16 weeks. The level of glycemic control in these patients was generally comparable to that observed in the 69 patients (60%) without antibody titer. An additional 10 patients (9%) had higher titer antibodies at 16 weeks. Of these patients, 4 (4% overall) had an attenuated glycemic response to BYETTA; the remaining 6 (5% overall) had a glycemic response comparable to that of patients without antibodies.</paragraph>
                        <paragraph>In the 24-week trial of BYETTA used as monotherapy, 40 patients (28%) had low titer antibodies to exenatide at 24 weeks. The level of glycemic control in these patients was generally comparable to that observed in the 101 patients (70%) without antibody titers. An additional 3 patients (2%) had higher titer antibodies at 24 weeks. Of these patients, 1 (1% overall) had an attenuated glycemic response to BYETTA; the remaining 2 (1% overall) had a glycemic response comparable to that of patients without antibodies.</paragraph>
                        <paragraph>Antibodies to exenatide were not assessed in the 30-week placebo-controlled trial of BYETTA used in combination with insulin glargine.</paragraph>
                        <paragraph>In the 30-week comparator-controlled trial of BYETTA used in combination with insulin glargine and metformin, 60 patients (20%) had low titer antibodies to exenatide at 30 weeks. The level of glycemic control in these patients was generally comparable to that observed in the 234 patients (77%) without antibody titers. An additional 10 patients (3%) had higher titer antibodies at 30 weeks. Of these patients, 2 (1% overall) had an attenuated glycemic response to BYETTA; the remaining 8 (3% overall) had a glycemic response comparable to that of patients without antibodies.</paragraph>
                        <paragraph>Two hundred and ten patients with antibodies to exenatide in the BYETTA clinical trials were tested for the presence of cross-reactive antibodies to GLP-1 and/or glucagon. No treatment-emergent cross-reactive antibodies were observed across the range of titers.</paragraph>
                        <paragraph>
                           <content styleCode="bold">Other Adverse Reactions</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="bold">
                              <content styleCode="italics">Monotherapy</content>
                           </content>
                        </paragraph>
                        <paragraph>For the 24-week placebo-controlled study of BYETTA used as a monotherapy, Table 2 summarizes adverse reactions (excluding hypoglycemia) occurring with an incidence â¥2% and occurring more frequently in BYETTA-treated patients compared with placebo-treated patients.</paragraph>
                        <table width="100%">
                           <caption>Table 2: Treatment-Emergent Adverse Reactions â¥2% Incidence with BYETTA used as Monotherapy (excluding Hypoglycemia)<footnote ID="_Ref516116753">In a 24-week placebo-controlled trial.</footnote>
                           </caption>
                           <col width="31%"/>
                           <col width="29%"/>
                           <col width="40%"/>
                           <thead>
                              <tr>
                                 <th align="left" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">Monotherapy</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">Placebo BID</content>
                                    <br/>
                                    <content styleCode="bold">N=77</content>
                                    <br/>
                                    <content styleCode="bold">%</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">All BYETTA BID</content>
                                    <br/>
                                    <content styleCode="bold">N=155</content>
                                    <br/>
                                    <content styleCode="bold">%</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Nausea</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Vomiting</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dyspepsia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" valign="top">
                                    <paragraph>BID = twice daily.</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Adverse reactions reported in â¥1.0% to &lt;2.0% of patients receiving BYETTA and reported more frequently than with placebo included decreased appetite, diarrhea, and dizziness. The most frequently reported adverse reaction associated with BYETTA, nausea, occurred in a dose-dependent fashion.</paragraph>
                        <paragraph>Two of the 155 patients treated with BYETTA withdrew due to adverse reactions of headache and nausea. No placebo-treated patients withdrew due to adverse reactions.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Cholelithiasis and cholecystitis </content>
                        </paragraph>
                        <paragraph>In a clinical study with exenatide, 1.9% of exenatide-treated patients and 1.4% of placebo-treated patients reported an acute event of gallbladder disease, such as cholelithiasis or cholecystitis.</paragraph>
                        <paragraph>
                           <content styleCode="bold">
                              <content styleCode="italics">Combination Therapy</content>
                           </content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="underline">Add-On to Metformin and/or Sulfonylurea</content>
                        </paragraph>
                        <paragraph>In the three 30-week controlled trials of BYETTA add-on to metformin and/or sulfonylurea, adverse reactions (excluding hypoglycemia) with an incidence â¥2% and occurring more frequently in BYETTA-treated patients compared with placebo-treated patients are summarized in Table 3.</paragraph>
                        <table width="100%">
                           <caption>Table 3: Treatment-Emergent Adverse Reactions â¥2% Incidence and Greater Incidence with BYETTA Treatment used with Metformin and/or a Sulfonylurea (excluding Hypoglycemia)<footnote ID="_Ref516117126">In three 30-week placebo-controlled clinical trials.</footnote>
                           </caption>
                           <col width="49%"/>
                           <col width="22%"/>
                           <col width="29%"/>
                           <thead>
                              <tr>
                                 <th align="left" styleCode="Rrule Botrule Lrule Toprule " valign="top"/>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">Placebo BID</content>
                                    <br/>
                                    <content styleCode="bold">N=483</content>
                                    <br/>
                                    <content styleCode="bold">%</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">All BYETTA BID</content>
                                    <br/>
                                    <content styleCode="bold">N=963</content>
                                    <br/>
                                    <content styleCode="bold">%</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Nausea</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>18</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>44</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Vomiting</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>13</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Diarrhea</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>6</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>13</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Feeling Jittery</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Dizziness</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>6</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Headache</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>6</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Dyspepsia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>6</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Asthenia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Gastroesophageal Reflux Disease</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Hyperhidrosis</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" valign="top">
                                    <paragraph>BID = twice daily</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Adverse reactions reported in â¥1.0% to &lt;2.0% of patients receiving BYETTA and reported more frequently than with placebo included decreased appetite. Nausea was the most frequently reported adverse reaction and occurred in a dose-dependent fashion. With continued therapy, the frequency and severity decreased over time in most of the patients who initially experienced nausea. Patients in the long-term uncontrolled open-label extension studies at 52 weeks reported no new types of adverse reactions than those observed in the 30-week controlled trials.</paragraph>
                        <paragraph>The most common adverse reactions leading to withdrawal for BYETTA-treated patients were nausea (3% of patients) and vomiting (1%). For placebo-treated patients, &lt;1% withdrew due to nausea and none due to vomiting.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Add-On to Thiazolidinedione with or without Metformin</content>
                        </paragraph>
                        <paragraph>For the 16-week placebo-controlled study of BYETTA add-on to a thiazolidinedione, with or without metformin, Table 4 summarizes the adverse reactions (excluding hypoglycemia) with an incidence of â¥2% and occurring more frequently in BYETTA-treated patients compared with placebo-treated patients.</paragraph>
                        <table width="100%">
                           <caption>Table 4: Treatment-Emergent Adverse Reactions â¥2% Incidence with BYETTA used with a Thiazolidinedione (TZD), with or without Metformin (MET) (excluding Hypoglycemia)<footnote ID="_Ref516117596">In a 16-week placebo-controlled clinical trial.</footnote>
                           </caption>
                           <col width="53%"/>
                           <col width="16%"/>
                           <col width="32%"/>
                           <thead>
                              <tr>
                                 <th align="left" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">With a TZD or TZD/MET</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">Placebo</content>
                                    <br/>
                                    <content styleCode="bold">N=112</content>
                                    <br/>
                                    <content styleCode="bold">%</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">All BYETTA BID</content>
                                    <br/>
                                    <content styleCode="bold">N=121</content>
                                    <br/>
                                    <content styleCode="bold">%</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Nausea</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>15</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>40</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Vomiting</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>13</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Dyspepsia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Diarrhea</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>6</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Gastroesophageal Reflux Disease</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" valign="top">
                                    <paragraph>BID = twice daily.</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Adverse reactions reported in â¥1.0% to &lt;2.0% of patients receiving BYETTA and reported more frequently than with placebo included decreased appetite. Chills (n=4) and injection-site reactions (n=2) occurred only in BYETTA-treated patients. The two patients who reported an injection-site reaction had high titers of antibodies to exenatide. Two serious adverse events (chest pain and chronic hypersensitivity pneumonitis) were reported in the BYETTA arm. No serious adverse events were reported in the placebo arm.</paragraph>
                        <paragraph>The most common adverse reactions leading to withdrawal for BYETTA-treated patients were nausea (9%) and vomiting (5%). For placebo-treated patients, &lt;1% withdrew due to nausea.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Add-On to Insulin Glargine with or without Metformin and/or Thiazolidinedione (Placebo-Controlled)</content>
                        </paragraph>
                        <paragraph>For the 30-week placebo-controlled study of BYETTA as add-on to insulin glargine with or without oral antihyperglycemic medications, Table 5 summarizes adverse reactions (excluding hypoglycemia) occurring with an incidence â¥2% and occurring more frequently in BYETTA-treated patients compared with placebo-treated patients.</paragraph>
                        <table width="100%">
                           <caption>Table 5: Treatment-Emergent Adverse Reactions â¥2% Incidence with BYETTA used with Insulin Glargine with or without Oral Antihyperglycemic Medications (excluding Hypoglycemia)<footnote ID="_Ref516117756">In a 30-week placebo-controlled clinical trial.</footnote>
                           </caption>
                           <col width="53%"/>
                           <col width="16%"/>
                           <col width="32%"/>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">With Insulin Glargine</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Placebo</content>
                                       <br/>
                                       <content styleCode="bold">N=122</content>
                                       <br/>
                                       <content styleCode="bold">%</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">All BYETTA BID</content>
                                       <br/>
                                       <content styleCode="bold">N=137</content>
                                       <br/>
                                       <content styleCode="bold">%</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Nausea</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>41</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Vomiting</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>18</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Diarrhea</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>18</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Headache</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>14</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Constipation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>10</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Dyspepsia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Asthenia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Abdominal Distension</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Decreased Appetite</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Flatulence</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Gastroesophageal Reflux Disease</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" valign="top">
                                    <paragraph>BID = twice daily.</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>The most frequently reported adverse reactions leading to withdrawal for BYETTA-treated patients were nausea (5.1%) and vomiting (2.9%). No placebo-treated patients withdrew due to nausea or vomiting.</paragraph>
                     </text>
                     <effectiveTime value="20241101"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_652bcd3d-50eb-4f98-84d7-d93344de1107">
                     <id root="19d6b1a5-c51a-43be-84ab-83143d0b11b7"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>6.2 Postmarketing Experience </title>
                     <text>
                        <paragraph>The following additional adverse reactions have been reported during post approval use of BYETTA or other formulations of exenatide. Because these events are reported voluntarily from a population of uncertain size, it is generally not possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Blood</content>: Drug induced thrombocytopenia. </paragraph>
                        <paragraph>
                           <content styleCode="italics">Drug Interactions</content>: International normalized ratio (INR) increased with concomitant warfarin use sometimes associated with bleeding <content styleCode="italics">[see <linkHtml href="#S7">Drug Interactions (7)</linkHtml>]</content>.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Gastrointestinal</content>: Nausea, vomiting, and/or diarrhea resulting in dehydration; abdominal distension, abdominal pain, eructation, constipation, flatulence, ileus, acute pancreatitis, hemorrhagic and necrotizing pancreatitis sometimes resulting in death</paragraph>
                        <paragraph>
                           <content styleCode="italics">Hepatobiliary</content>: Cholecystitis, cholelithiasis requiring cholecystectomy.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Hypersensitivity</content>: Injection-site reactions, generalized pruritus and/or urticaria, macular or papular rash, angioedema, anaphylactic reaction. </paragraph>
                        <paragraph>
                           <content styleCode="italics">Neurologic</content>: Dysgeusia, somnolence, dysesthesia.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Pulmonary</content>: Pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Renal</content>: Altered renal function, including increased serum creatinine, renal impairment, worsened chronic renal failure or acute renal failure (sometimes requiring hemodialysis), kidney transplant, and kidney transplant dysfunction.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Skin and Subcutaneous Tissue</content>: Alopecia.</paragraph>
                     </text>
                     <effectiveTime value="20250528"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S7">
               <id root="8b3fe708-031d-455e-9b1d-e8c39e439404"/>
               <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
               <title>7 DRUG INTERACTIONS</title>
               <effectiveTime value="20250528"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>May impact absorption of orally administered medications. (<linkHtml href="#S7">7</linkHtml>)</item>
                           <item>
                              <caption>â¢</caption>Warfarin: Postmarketing reports of increased INR sometimes associated with bleeding. Monitor INR frequently until stable upon initiation or alteration of BYETTA therapy. (<linkHtml href="#S7">7</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_eb9215ad-a0d2-4028-92ef-c45c19145e24">
                     <id root="d35f5cc0-4196-4517-8606-2f859370b4a4"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Generic Section </title>
                     <text>
                        <table width="98.44%">
                           <col width="19%"/>
                           <col width="81%"/>
                           <thead>
                              <tr>
                                 <th align="left" colspan="2" valign="top">
                                    <content styleCode="italics"/>
                                    <content styleCode="bold">Table 6: Clinically Relevant Interactions with BYETTA</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Concomitant Use of Insulin Secretagogues or Insulin </content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Clinical Impact</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Exenatide promotes insulin release from pancreatic beta-cells in the presence of elevated glucose concentrations. The risk of hypoglycemia is increased when exenatide is used in combination with insulin secretagogues (e.g., sulfonylureas) or insulin <content styleCode="italics">[see <linkHtml href="#_5.3_Hypoglycemia_">Warnings and Precautions (5.3)</linkHtml> and <linkHtml href="#ID_652bcd3d-50eb-4f98-84d7-d93344de1107">Adverse Reactions (6)</linkHtml>]</content>.</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Intervention</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>When initiating BYETTA, consider reducing the dose of concomitantly administered insulin secretagogue or insulin to reduce the risk of hypoglycemia.</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Warfarin</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Clinical Impact</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>In a drug interaction study, BYETTA did not have a significant effect on INR <content styleCode="italics">[see <linkHtml href="#S12.3">Clinical Pharmacology (12.3)</linkHtml>]</content>. There have been postmarketing reports for BYETTA of increased INR with concomitant use of warfarin, sometimes associated with bleeding <content styleCode="italics">[see </content>
                                       <content styleCode="italics">
                                          <linkHtml href="#S12.3">Adverse Reactions (6.2)</linkHtml>
                                       </content>
                                       <content styleCode="italics">]</content>.</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Intervention</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>In patients taking warfarin, the prothrombin time should be monitored more frequently after initiation or alteration of BYETTA therapy. Once a stable prothrombin time has been documented, the prothrombin time can be monitored at the intervals recommended for patients taking warfarin.</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Orally Administered Drugs (e.g., acetaminophen)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Clinical Impact</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Exenatide slows gastric emptying. Therefore, BYETTA has the potential to reduce the rate of absorption of orally administered drugs <content styleCode="italics">[see <linkHtml href="#S12.3">Clinical Pharmacology (12.3)</linkHtml>].</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>Intervention</paragraph>
                                 </td>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>Use caution when administering oral medications with BYETTA where a slower rate of oral absorption may be clinically meaningful. For oral medications that are dependent on threshold concentrations for efficacy, such as contraceptives and antibiotics, patients should be advised to take those drugs at least 1 hour before BYETTA injection. If such drugs are to be administered with food, patients should be advised to take them with a meal or snack when BYETTA is not administered <content styleCode="italics">[see<linkHtml href="#S12.3"> Clinical Pharmacology (12.3)</linkHtml>]</content>.</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20250528"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S8">
               <id root="b2ab4f9d-3a61-4ab2-b234-6a9bf79fbf6c"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS</title>
               <effectiveTime value="20250528"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>Pregnancy: Use during pregnancy only if the potential benefit justifies the risk to the fetus. <linkHtml href="#S8.1">(8.1)</linkHtml>
                           </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="S8.1">
                     <id root="b7f7b299-f7fb-4598-b26c-a9a5f852e7f1"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>8.1 Pregnancy</title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Risk Summary</content>
                        </paragraph>
                        <paragraph>Limited data with BYETTA in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. There are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy <content styleCode="italics">(see <linkHtml href="#ClinicalConsiderations_8_1">Clinical Considerations</linkHtml>).</content> Based on animal reproduction studies, there may be risks to the fetus from exposure to BYETTA during pregnancy. BYETTA should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. </paragraph>
                        <paragraph>Animal reproduction studies identified increased adverse fetal and neonatal outcomes from exposure to exenatide during pregnancy and lactation in association with maternal effects. In mice, exenatide administered during gestation and lactation caused increased neonatal deaths at systemic exposure 3-times the human exposure resulting from the maximum recommended human dose (MRHD) of 20 mcg/day for BYETTA <content styleCode="italics">(see <linkHtml href="#Data_8_1">Data</linkHtml>)</content>. </paragraph>
                        <paragraph>The estimated background risk of major birth defects is 6-10% in women with pre-gestational diabetes with an HbA1c &gt;7 and has been reported to be as high as 20-25% in women with HbA1c &gt;10. The estimated background risk of miscarriage for the indicated population is unknown. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively.</paragraph>
                        <paragraph ID="ClinicalConsiderations_8_1">Clinical Considerations</paragraph>
                        <paragraph>
                           <content styleCode="italics">Disease-associated maternal and/or embryofetal risk</content>
                        </paragraph>
                        <paragraph>Poorly controlled diabetes in pregnancy increases the maternal risk for diabetic ketoacidosis, preeclampsia, spontaneous abortions, preterm delivery, and delivery complications. Poorly controlled diabetes increases the fetal risk for major birth defects, stillbirth, and macrosomia related morbidity.</paragraph>
                        <paragraph ID="Data_8_1">
                           <content styleCode="underline">Data</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Animal Data</content>
                        </paragraph>
                        <paragraph>In studies evaluating reproduction and development in pregnant mice and rabbits, maternal animals were administered exenatide, the active ingredient in BYETTA, by subcutaneous injection twice a day. </paragraph>
                        <paragraph>In pregnant mice given 6, 68, 460, or 760 mcg/kg/day exenatide during fetal organogenesis, skeletal variations associated with slowed fetal growth, including changes in number of rib pairs or vertebral ossifications sites, and wavy ribs were observed at 760 mcg/kg/day, a dose that produced maternal toxicity and yielded systemic exposure 390-times the human exposure resulting from the MRHD of BYETTA based on AUC comparison.</paragraph>
                        <paragraph>In pregnant rabbits given 0.2, 2, 22, 156, or 260 mcg/kg/day exenatide during fetal organogenesis, irregular fetal skeletal ossifications were observed at 2 mcg/kg/day, a dose yielding systemic exposure up to 12-times the human exposure from the MRHD of BYETTA based on AUC comparison.</paragraph>
                        <paragraph>In maternal mice given 6, 68, or 760 mcg/kg/day exenatide from gestation day 6 through lactation day 20 (weaning), an increased number of neonatal deaths was observed on postpartum days 2 to 4 in dams given 6 mcg/kg/day, a dose yielding a systemic exposure 3-times the human exposure from the MRHD of BYETTA based on AUC comparison.</paragraph>
                     </text>
                     <effectiveTime value="20241101"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_386C1CDA-85E1-4E7B-8572-C8D253381333">
                     <id root="d0389560-5e2a-49d3-9a80-a64070479ae5"/>
                     <code code="77290-5" codeSystem="2.16.840.1.113883.6.1" displayName="LACTATION SECTION"/>
                     <title>8.2 Lactation </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Risk Summary</content>
                        </paragraph>
                        <paragraph>There is no information regarding the presence of BYETTA, in human milk, the effects of BYETTA on the breastfed infant, or the effects of BYETTA on milk production. Exenatide was present in the milk of lactating mice. However, due to species-specific differences in lactation physiology, the clinical relevance of these data is not clear <content styleCode="italics">(see <linkHtml href="#ID_386C1CDA-85E1-4E7B-8572-C8D253381333">Data</linkHtml>)</content>. The developmental and health benefits of breastfeeding should be considered along with the motherâs clinical need for BYETTA and any potential adverse effects on the breastfed child from BYETTA or from the underlying maternal condition.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Data</content>
                        </paragraph>
                        <paragraph>In lactating mice subcutaneously injected twice a day with exenatide, the concentration of exenatide in milk was up to 2.5% of the concentration in maternal plasma.</paragraph>
                     </text>
                     <effectiveTime value="20241101"/>
                  </section>
               </component>
               <component>
                  <section ID="S8.4">
                     <id root="65e7b4a7-1ad7-4496-b2c5-979d62460324"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>8.4 Pediatric Use</title>
                     <text>
                        <paragraph>The Safety and effectiveness of BYETTA have not been established in pediatric patients.</paragraph>
                        <paragraph>Effectiveness of BYETTA was not demonstrated in a randomized, double-blind, placebo-controlled study conducted in 120 pediatric patients (78 received BYETTA and 42 received placebo) aged 10 to 17 years with type 2 diabetes mellitus.</paragraph>
                     </text>
                     <effectiveTime value="20221221"/>
                  </section>
               </component>
               <component>
                  <section ID="S8.5">
                     <id root="035f3b88-c370-4464-91f3-9f1b851e058f"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>8.5 Geriatric Use</title>
                     <text>
                        <paragraph>Population pharmacokinetic analysis of patients ranging from 22 to 73 years of age suggests that age does not influence the pharmacokinetic properties of exenatide <content styleCode="italics">[see <linkHtml href="#S12.3">Clinical Pharmacology (12.3)</linkHtml>]</content>. BYETTA was studied in 282 patients 65 years of age or older and in 16 patients 75 years of age or older. No differences in safety or effectiveness were observed between these patients and younger patients. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection in the elderly based on renal function.</paragraph>
                     </text>
                     <effectiveTime value="20181221"/>
                  </section>
               </component>
               <component>
                  <section ID="S8.6">
                     <id root="c46455a4-3fb8-4316-bbba-a19425882338"/>
                     <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
                     <title>8.6 Renal Impairment</title>
                     <text>
                        <paragraph>BYETTA is not recommended for use in patients with end-stage renal disease or severe renal impairment (creatinine clearance &lt;30 mL/min) and should be used with caution in patients with renal transplantation. In patients with end-stage renal disease receiving dialysis, single doses of BYETTA 5 mcg were not well tolerated due to gastrointestinal adverse reactions. <content styleCode="italics">[see <linkHtml href="#S12.3">Clinical Pharmacology (12.3)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20250528"/>
                  </section>
               </component>
               <component>
                  <section ID="S8.7">
                     <id root="9f5745ed-5c2d-4c1f-b224-123a63116f01"/>
                     <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
                     <title>8.7 Hepatic Impairment</title>
                     <text>
                        <paragraph>No pharmacokinetic study has been performed in patients with a diagnosis of acute or chronic hepatic impairment. Because exenatide is cleared primarily by the kidney, hepatic dysfunction is not expected to affect blood concentrations of exenatide <content styleCode="italics">[see <linkHtml href="#S12.3">Clinical Pharmacology (12.3)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20181221"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S10">
               <id root="6895bae6-7c75-47aa-b30f-74f72776daba"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>10 OVERDOSAGE</title>
               <text>
                  <paragraph>In a clinical study of BYETTA, three patients with type 2 diabetes each experienced a single overdose of 100 mcg SC (10 times the maximum recommended dose). Effects of the overdoses included severe nausea, severe vomiting, and rapidly declining blood glucose concentrations. One of the three patients experienced severe hypoglycemia requiring parenteral glucose administration. The three patients recovered without complication. In the event of overdose, consider contacting the Poison Help line (1-800-222-1222) or a medical toxicologist for additional overdosage management recommendations. Initiate appropriate supportive treatment according to the patient's clinical signs and symptoms.</paragraph>
               </text>
               <effectiveTime value="20250528"/>
            </section>
         </component>
         <component>
            <section ID="S11">
               <id root="dd4e8b7d-559b-4380-aab7-7fb413f9a4ed"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION</title>
               <text>
                  <paragraph>BYETTA (exenatide) is a synthetic peptide, GLP-1 receptor agonist, that was originally identified in the lizard <content styleCode="italics">Heloderma suspectum</content>.</paragraph>
                  <paragraph>Exenatide is a 39-amino acid peptide amide. Exenatide has the empirical formula C<sub>184</sub>H<sub>282</sub>N<sub>50</sub>O<sub>60</sub>S and molecular weight of 4186.6 Daltons. The amino acid sequence for exenatide is shown below.</paragraph>
                  <paragraph>H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH<sub>2</sub>
                  </paragraph>
                  <paragraph>BYETTA injection is supplied for subcutaneous administration as a sterile, preserved isotonic solution in a glass cartridge that has been assembled in a pen-injector (pen). Each milliliter (mL) contains 250 micrograms (mcg) synthetic exenatide, 2.2 mg metacresol as an antimicrobial preservative, mannitol as a tonicity-adjusting agent, and glacial acetic acid and sodium acetate trihydrate in water for injection as a buffering solution at pH 4.5. Two prefilled pens are available to deliver unit doses of 5 mcg or 10 mcg. Each prefilled pen will deliver 60 doses to provide for 30 days of twice daily administration (BID).</paragraph>
               </text>
               <effectiveTime value="20250528"/>
            </section>
         </component>
         <component>
            <section ID="S12">
               <id root="9dc1e414-2414-4045-a932-6773134c1f41"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY</title>
               <effectiveTime value="20250528"/>
               <component>
                  <section ID="S12.1">
                     <id root="defc79fc-ee72-4ada-83eb-93936cb8d984"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1 Mechanism of Action</title>
                     <text>
                        <paragraph>Incretins, such as glucagon-like peptide-1 (GLP-1), enhance glucose-dependent insulin secretion and exhibit other antihyperglycemic actions following their release into the circulation from the gut. BYETTA is a GLP-1 receptor agonist that enhances glucose-dependent insulin secretion by the pancreatic beta-cell, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying.</paragraph>
                        <paragraph>The amino acid sequence of exenatide partially overlaps that of human GLP-1. Exenatide has been shown to bind and activate the human GLP-1 receptor <content styleCode="italics">in vitro</content>. This leads to an increase in both glucose-dependent synthesis of insulin, and <content styleCode="italics">in vivo</content> secretion of insulin from pancreatic beta cells, by mechanisms involving cyclic AMP and/or other intracellular signaling pathways.</paragraph>
                        <paragraph>BYETTA improves glycemic control by reducing fasting and postprandial glucose concentrations in patients with type 2 diabetes through the actions described below.</paragraph>
                     </text>
                     <effectiveTime value="20181221"/>
                  </section>
               </component>
               <component>
                  <section ID="S12.2">
                     <id root="9142608d-b5f5-4d85-adce-ec9f314b4cbb"/>
                     <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                     <title>12.2 Pharmacodynamics</title>
                     <effectiveTime value="20181221"/>
                     <component>
                        <section ID="S12.2.1">
                           <id root="e33fa4fe-3577-43ad-b833-4a47c9bb964b"/>
                           <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                           <title>
                              <content styleCode="bold">Glucose-Dependent Insulin Secretion</content>
                           </title>
                           <text>
                              <paragraph>BYETTA has acute effects on pancreatic beta-cell responsiveness to glucose leading to insulin release predominantly in the presence of elevated glucose concentrations. This insulin secretion subsides as blood glucose concentrations decrease and approach euglycemia. However, BYETTA does not impair the normal glucagon response to hypoglycemia.</paragraph>
                           </text>
                           <effectiveTime value="20141211"/>
                        </section>
                     </component>
                     <component>
                        <section ID="S12.2.2">
                           <id root="74fcfcdc-f241-4346-9214-ac7c36b8e967"/>
                           <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                           <title>
                              <content styleCode="bold">First-Phase Insulin Response</content>
                           </title>
                           <text>
                              <paragraph>In healthy individuals, robust insulin secretion occurs during the first 10 minutes following intravenous (IV) glucose administration. This secretion, known as the "first-phase insulin response," is characteristically absent in patients with type 2 diabetes. The loss of the first-phase insulin response is an early beta-cell defect in type 2 diabetes. Administration of BYETTA at therapeutic plasma concentrations restored first-phase insulin response to an IV bolus of glucose in patients with type 2 diabetes (Figure 1). Both first-phase insulin secretion and second-phase insulin secretion were significantly increased in patients with type 2 diabetes treated with BYETTA compared with saline (p&lt;0.001 for both).</paragraph>
                              <paragraph>
                                 <content styleCode="bold">Figure 1: Mean (+SEM) Insulin Secretion Rate during Infusion of BYETTA or Saline in Patients with Type 2 Diabetes and during Infusion of Saline in Healthy Subjects</content>
                              </paragraph>
                              <renderMultiMedia ID="id1352" referencedObject="a96b7a87-22fa-48c2-8013-dc0941360057"/>
                           </text>
                           <effectiveTime value="20141211"/>
                           <component>
                              <observationMedia ID="a96b7a87-22fa-48c2-8013-dc0941360057">
                                 <text>Figure 1</text>
                                 <value mediaType="image/jpeg" xsi:type="ED">
                                    <reference value="byetta-01.jpg"/>
                                 </value>
                              </observationMedia>
                           </component>
                        </section>
                     </component>
                     <component>
                        <section ID="S12.2.3">
                           <id root="96df8072-22e1-4caf-985b-79411624ef7c"/>
                           <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                           <title>
                              <content styleCode="bold">Glucagon Secretion</content>
                           </title>
                           <text>
                              <paragraph>In patients with type 2 diabetes, BYETTA moderates glucagon secretion and lowers serum glucagon concentrations during periods of hyperglycemia. Lower glucagon concentrations lead to decreased hepatic glucose output and decreased insulin demand.</paragraph>
                           </text>
                           <effectiveTime value="20141211"/>
                        </section>
                     </component>
                     <component>
                        <section ID="S12.2.4">
                           <id root="1ccad712-8a59-442b-b4ee-3991231fad3f"/>
                           <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                           <title>
                              <content styleCode="bold">Gastric Emptying</content>
                           </title>
                           <text>
                              <paragraph>BYETTA slows gastric emptying, thereby reducing the rate at which meal-derived glucose appears in the circulation.</paragraph>
                           </text>
                           <effectiveTime value="20141211"/>
                        </section>
                     </component>
                     <component>
                        <section ID="S12.2.5">
                           <id root="c56eca4d-cb9a-463d-88ea-b3daaa665914"/>
                           <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                           <title>
                              <content styleCode="bold">Food Intake</content>
                           </title>
                           <text>
                              <paragraph>In both animals and humans, administration of exenatide has been shown to reduce food intake.</paragraph>
                           </text>
                           <effectiveTime value="20141211"/>
                        </section>
                     </component>
                     <component>
                        <section ID="S12.2.6">
                           <id root="8a8e1d5e-a1c8-4515-87dc-7d1c6863369a"/>
                           <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                           <title>
                              <content styleCode="bold">Postprandial Glucose</content>
                           </title>
                           <text>
                              <paragraph>In patients with type 2 diabetes, BYETTA reduces postprandial plasma glucose concentrations (Figure 2).</paragraph>
                              <paragraph>
                                 <content styleCode="bold">Figure 2: Mean (+SEM) Postprandial Plasma Glucose Concentrations on Day 1 of BYETTA<sup>a</sup> Treatment in Patients with Type 2 Diabetes Treated with Metformin, a Sulfonylurea, or Both (N=54)</content>
                              </paragraph>
                              <renderMultiMedia ID="id1393" referencedObject="a094e9b1-d418-413c-96f3-ed362ab4343f"/>
                           </text>
                           <effectiveTime value="20141211"/>
                           <component>
                              <observationMedia ID="a094e9b1-d418-413c-96f3-ed362ab4343f">
                                 <text>Figure 2</text>
                                 <value mediaType="image/jpeg" xsi:type="ED">
                                    <reference value="byetta-02.jpg"/>
                                 </value>
                              </observationMedia>
                           </component>
                        </section>
                     </component>
                     <component>
                        <section ID="S12.2.7">
                           <id root="f9d8b98b-e022-4f3f-80f6-cd2228a65249"/>
                           <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                           <title>
                              <content styleCode="bold">Fasting Glucose</content>
                           </title>
                           <text>
                              <paragraph>In a single-dose crossover study in patients with type 2 diabetes and fasting hyperglycemia, immediate insulin release followed injection of BYETTA. Plasma glucose concentrations were significantly reduced with BYETTA compared with placebo (Figure 3).</paragraph>
                              <paragraph>
                                 <content styleCode="bold">Figure 3: Mean (+SEM) Serum Insulin and Plasma Glucose Concentrations Following a One-Time Injection of BYETTA<sup>a</sup> or Placebo in Fasting Patients with Type 2 Diabetes (N=12)</content>
                              </paragraph>
                              <renderMultiMedia ID="id1410" referencedObject="ID_3c4986f0-c546-4285-9ff3-d601d7237046"/>
                           </text>
                           <effectiveTime value="20181221"/>
                           <component>
                              <observationMedia ID="ID_3c4986f0-c546-4285-9ff3-d601d7237046">
                                 <text>Figure 3</text>
                                 <value mediaType="image/jpeg" xsi:type="ED">
                                    <reference value="byetta-03.jpg"/>
                                 </value>
                              </observationMedia>
                           </component>
                        </section>
                     </component>
                     <component>
                        <section ID="S12.2.8">
                           <id root="b0dbd4ae-1425-46a0-b9e0-6bb2e57b3411"/>
                           <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                           <title>
                              <content styleCode="bold">Cardiac Electrophysiology</content>
                           </title>
                           <text>
                              <paragraph>The effect of exenatide 10 Âµg subcutaneously on QTc interval was evaluated in a randomized, placebo-, and active-controlled (moxifloxacin 400 mg) crossover thorough QTc study in 62 healthy subjects. In this study with demonstrated ability to detect small effects, the upper bound of the 90% confidence interval for the largest placebo-adjusted, baseline-corrected QTc was below 10 msec. Thus, BYETTA (10 mcg single dose) was not associated with clinically meaningful prolongation of the QTc interval.</paragraph>
                           </text>
                           <effectiveTime value="20141211"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="S12.3">
                     <id root="9538c33e-9c67-467b-ab51-2694d643dd69"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>12.3 Pharmacokinetics</title>
                     <effectiveTime value="20250528"/>
                     <component>
                        <section ID="S12.3.1">
                           <id root="f993763d-a8be-4734-90b0-211703f9455e"/>
                           <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                           <title>
                              <content styleCode="bold">Absorption</content>
                           </title>
                           <text>
                              <paragraph>Following SC administration to patients with type 2 diabetes, exenatide reaches median peak plasma concentrations in 2.1 hours. The mean peak exenatide concentration (C<sub>max</sub>) was 211 pg/mL and overall mean area under the time-concentration curve (AUC<sub>0-inf</sub>) was 1036 pgâh/mL following SC administration of a 10-mcg dose of BYETTA. Exenatide exposure (AUC) increased proportionally over the therapeutic dose range of 5 to 10 mcg. The C<sub>max</sub> values increased less than proportionally over the same range. Similar exposure is achieved with SC administration of BYETTA in the abdomen, thigh, or upper arm.</paragraph>
                           </text>
                           <effectiveTime value="20141211"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s12.3.2">
                           <id root="ef0720bd-8157-45de-ac67-ad9041c218b4"/>
                           <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                           <title>
                              <content styleCode="bold">Distribution</content>
                           </title>
                           <text>
                              <paragraph>The mean apparent volume of distribution of exenatide following SC administration of a single dose of BYETTA is 28.3 L.</paragraph>
                           </text>
                           <effectiveTime value="20141211"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s12.3.3">
                           <id root="132247f9-9646-498b-8cc6-1874f9a55dfd"/>
                           <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                           <title>
                              <content styleCode="bold">Metabolism and Elimination</content>
                           </title>
                           <text>
                              <paragraph>Nonclinical studies have shown that exenatide is predominantly eliminated by glomerular filtration with subsequent proteolytic degradation. The mean apparent clearance of exenatide in humans is 9.1 L/hour and the mean terminal half-life is 2.4 hours. These pharmacokinetic characteristics of exenatide are independent of the dose. In most individuals, exenatide concentrations are measurable for approximately 10 hours post-dose.</paragraph>
                           </text>
                           <effectiveTime value="20141211"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s12.3.4">
                           <id root="c37d1263-7512-4a82-b963-980b06dc260a"/>
                           <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                           <title>
                              <content styleCode="bold">Drug Interactions</content>
                           </title>
                           <effectiveTime value="20250528"/>
                           <component>
                              <section ID="s12.3.4.1">
                                 <id root="5c4b8425-eeef-4c90-a2b5-5736dfcc6e90"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">Acetaminophen</content>
                                 </title>
                                 <text>
                                    <paragraph>When 1000 mg acetaminophen elixir was given with 10 mcg BYETTA (0 hour) and 1 hour, 2 hours, and 4 hours after BYETTA injection, acetaminophen AUCs were decreased by 21%, 23%, 24%, and 14%, respectively; C<sub>max</sub> was decreased by 37%, 56%, 54%, and 41%, respectively; T<sub>max</sub> was increased from 0.6 hour in the control period to 0.9 hour, 4.2 hours, 3.3 hours, and 1.6 hours, respectively. Acetaminophen AUC, C<sub>max</sub> and T<sub>max</sub> were not significantly changed when acetaminophen was given 1 hour before BYETTA injection.</paragraph>
                                 </text>
                                 <effectiveTime value="20141211"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s12.3.4.2">
                                 <id root="cfabf07a-2215-47cb-8995-10335544bdbb"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">Digoxin</content>
                                 </title>
                                 <text>
                                    <paragraph>Administration of repeated doses of BYETTA (10 mcg BID) 30 minutes before oral digoxin (0.25 mg once daily) decreased the C<sub>max</sub> of digoxin by 17% and delayed the T<sub>max</sub> of digoxin by approximately 2.5 hours; however, the overall steady-state pharmacokinetic exposure (e.g., AUC) of digoxin was not changed.</paragraph>
                                 </text>
                                 <effectiveTime value="20141211"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s12.3.4.3">
                                 <id root="f4350381-9b68-4dc7-bdcb-bd36939b57eb"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">Lovastatin</content>
                                 </title>
                                 <text>
                                    <paragraph>Administration of BYETTA (10 mcg BID) 30 minutes before a single oral dose of lovastatin (40 mg) decreased the AUC and C<sub>max </sub>of lovastatin by approximately 40% and 28%, respectively, and delayed the T<sub>max</sub> by about 4 hours compared with lovastatin administered alone. In the 30-week controlled clinical trials of BYETTA, the use of BYETTA in patients already receiving HMG CoA reductase inhibitors was not associated with consistent changes in lipid profiles compared to baseline.</paragraph>
                                 </text>
                                 <effectiveTime value="20141211"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s12.3.4.4">
                                 <id root="1b0a0cf3-6eeb-4f4f-bb90-8c382d8f6a56"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">Lisinopril</content>
                                 </title>
                                 <text>
                                    <paragraph>In patients with mild to moderate hypertension stabilized on lisinopril (5-20 mg/day), BYETTA (10 mcg BID) did not alter steady-state C<sub>max</sub> or AUC of lisinopril. Lisinopril steady-state T<sub>max</sub> was delayed by 2 hours. There were no changes in 24-hour mean systolic and diastolic blood pressure.</paragraph>
                                 </text>
                                 <effectiveTime value="20141211"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s12.3.4.5">
                                 <id root="0d37d614-0a23-4db2-9f34-4b682cb9d941"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">Oral Contraceptives</content>
                                 </title>
                                 <text>
                                    <paragraph>The effect of BYETTA (10 mcg BID) on single and on multiple doses of a combination oral contraceptive (30 mcg ethinyl estradiol plus 150 mcg levonorgestrel) was studied in healthy female subjects. Repeated daily doses of the oral contraceptive (OC) given 30 minutes after BYETTA administration decreased the C<sub>max</sub> of ethinyl estradiol and levonorgestrel by 45% and 27%, respectively, and delayed the T<sub>max</sub> of ethinyl estradiol and levonorgestrel by 3.0 hours and 3.5 hours, respectively, as compared to the oral contraceptive administered alone. Administration of repeated daily doses of the OC one hour prior to BYETTA administration decreased the mean C<sub>max</sub> of ethinyl estradiol by 15% but the mean C<sub>max</sub> of levonorgestrel was not significantly changed as compared to when the OC was given alone. BYETTA did not alter the mean trough concentrations of levonorgestrel after repeated daily dosing of the oral contraceptive for both regimens. However, the mean trough concentration of ethinyl estradiol was increased by 20% when the OC was administered 30 minutes after BYETTA administration injection as compared to when the OC was given alone. The effect of BYETTA on OC pharmacokinetics is confounded by the possible food effect on OC in this study. Therefore, OC products should be administered at least one hour prior to BYETTA injection.</paragraph>
                                 </text>
                                 <effectiveTime value="20181221"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s12.3.4.6">
                                 <id root="9f555055-9b41-4aa0-b9b0-7093d09cc76f"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">Warfarin</content>
                                 </title>
                                 <text>
                                    <paragraph>Administration of warfarin (25 mg) 35 minutes after repeated doses of BYETTA (5 mcg BID on Days 1-2 and 10 mcg BID on Days 3-9) in healthy volunteers delayed warfarin T<sub>max</sub> by approximately 2 hours. No clinically relevant effects on C<sub>max</sub> or AUC of <content styleCode="italics">S</content>- and <content styleCode="italics">R</content>-enantiomers of warfarin were observed. BYETTA did not significantly alter the pharmacodynamic properties (e.g., international normalized ratio) of warfarin <content styleCode="italics">[see </content>
                                       <content styleCode="italics">
                                          <linkHtml href="#S7">Drug Interactions (7)</linkHtml>
                                       </content>
                                       <content styleCode="italics">]</content>.</paragraph>
                                 </text>
                                 <effectiveTime value="20250528"/>
                              </section>
                           </component>
                        </section>
                     </component>
                     <component>
                        <section ID="S12.3.5">
                           <id root="22a8201c-4edf-44e1-a29d-97b9b77409ef"/>
                           <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                           <title>
                              <content styleCode="bold">Specific Populations</content>
                           </title>
                           <effectiveTime value="20250528"/>
                           <component>
                              <section ID="s12.3.5.1">
                                 <id root="f2c1ae67-ed80-43f3-a6ed-c32929651396"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">
                                       <content styleCode="italics">Patients with Renal Impairment</content>
                                    </content>
                                 </title>
                                 <text>
                                    <paragraph>Pharmacokinetics of exenatide was studied in subjects with normal, mild, or moderate renal impairment and subjects with end-stage renal disease. In subjects with mild to moderate renal impairment (creatinine clearance 30-80 mL/min), exenatide exposure was similar to that of subjects with normal renal function. However, in subjects with end-stage renal disease receiving dialysis, mean exenatide exposure increased by 3.37-fold compared to that of subjects with normal renal function <content styleCode="italics">[see<linkHtml href="#S8.6"> Use in Specific Populations (8.6)</linkHtml>]</content>.</paragraph>
                                 </text>
                                 <effectiveTime value="20250528"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s12.3.5.2">
                                 <id root="946fd219-68c4-4b97-a35f-4ba259447acb"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">
                                       <content styleCode="italics">Patients with Hepatic Impairment</content>
                                    </content>
                                 </title>
                                 <text>
                                    <paragraph>No pharmacokinetic study has been performed in patients with a diagnosis of acute or chronic hepatic impairment <content styleCode="italics">[see<linkHtml href="#S8.7"> Use in Specific Populations (8.7)</linkHtml>].</content>
                                    </paragraph>
                                 </text>
                                 <effectiveTime value="20250528"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s12.3.5.3">
                                 <id root="b1fbdcbb-3ad8-4239-a5c3-601cd83e13d2"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">Age</content>
                                 </title>
                                 <text>
                                    <paragraph>Population pharmacokinetic analysis of patients ranging from 22 to 73 years of age suggests that age does not influence the pharmacokinetic properties of exenatide <content styleCode="italics">[see<linkHtml href="#S8.5"> Use in Specific Population (8.5)</linkHtml>]</content>.</paragraph>
                                 </text>
                                 <effectiveTime value="20181221"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s12.3.5.4">
                                 <id root="34cb4cec-0950-4ce4-9c2b-9ac5d41c3c0f"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">Male and Female Patients</content>
                                 </title>
                                 <text>
                                    <paragraph>Population pharmacokinetic analysis of male and female patients suggests that gender does not influence the distribution and elimination of exenatide.</paragraph>
                                 </text>
                                 <effectiveTime value="20250528"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s12.3.5.5">
                                 <id root="83397b98-85e4-4758-a1a9-d07c88aef046"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">Racial or Ethnic Groups</content>
                                 </title>
                                 <text>
                                    <paragraph>Population pharmacokinetic analysis of samples from White, Hispanic or Latino ethnicity, Asian, and Black or African American patients suggests that race has no significant influence on the pharmacokinetics of exenatide.</paragraph>
                                 </text>
                                 <effectiveTime value="20250528"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s12.3.5.6">
                                 <id root="1bba96f6-eb1a-4d5b-8018-40606447b402"/>
                                 <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                                 <title>
                                    <content styleCode="bold">Body Mass Index</content>
                                 </title>
                                 <text>
                                    <paragraph>Population pharmacokinetic analysis of patients with body mass indices (BMI) â¥30 kg/m<sup>2</sup> and &lt;30 kg/m<sup>2 </sup>suggests that BMI has no significant effect on the pharmacokinetics of exenatide.</paragraph>
                                 </text>
                                 <effectiveTime value="20141211"/>
                              </section>
                           </component>
                        </section>
                     </component>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S13">
               <id root="09a6b628-dafa-4b85-b180-106af474a839"/>
               <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="NONCLINICAL TOXICOLOGY SECTION"/>
               <title>13 NONCLINICAL TOXICOLOGY</title>
               <effectiveTime value="20221221"/>
               <component>
                  <section ID="S13.1">
                     <id root="301042af-a36b-4539-8674-667be43cedc3"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility</title>
                     <text>
                        <paragraph>A 104-week carcinogenicity study was conducted in male and female rats at doses of 18, 70, or 250 mcg/kg/day administered by bolus SC injection. Benign thyroid C-cell adenomas were observed in female rats at all exenatide doses. The incidences in female rats were 8% and 5% in the two control groups and 14%, 11%, and 23% in the low-, medium-, and high-dose groups with systemic exposures of 5-, 22-, and 130-times, respectively, the human exposure resulting from the maximum recommended dose of 20 mcg/day, based on plasma area under the curve (AUC).</paragraph>
                        <paragraph>In a 104-week carcinogenicity study in mice at doses of 18, 70, or 250 mcg/kg/day administered by bolus SC injection, no evidence of tumors was observed at doses up to 250 mcg/kg/day, a systemic exposure up to 95-times the human exposure resulting from the maximum recommended dose of 20 mcg/day, based on AUC.</paragraph>
                        <paragraph>Exenatide was not mutagenic or clastogenic, with or without metabolic activation, in the Ames bacterial mutagenicity assay or chromosomal aberration assay in Chinese hamster ovary cells. Exenatide was negative in the <content styleCode="italics">in vivo</content> mouse micronucleus assay.</paragraph>
                        <paragraph>In mouse fertility studies with SC doses of 6, 68, or 760 mcg/kg/day, males were treated for 4 weeks prior to and throughout mating, and females were treated 2 weeks prior to mating and throughout mating until gestation day 7. No adverse effect on fertility was observed at 760 mcg/kg/day, a systemic exposure 390-times the human exposure resulting from the maximum recommended dose of 20 mcg/day, based on AUC.</paragraph>
                     </text>
                     <effectiveTime value="20221221"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_00eafa89-0751-4a85-a506-88a98705f88c">
               <id root="0995d4c9-983c-4c0f-bda6-ef541841c30d"/>
               <code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL STUDIES SECTION"/>
               <title>14 CLINICAL STUDIES </title>
               <text>
                  <paragraph>BYETTA has been studied as monotherapy and in combination with metformin, a sulfonylurea, a thiazolidinedione, a combination of metformin and a sulfonylurea, a combination of metformin and a thiazolidinedione, or in combination with insulin glargine with or without metformin and/or thiazolidinedione.</paragraph>
               </text>
               <effectiveTime value="20250528"/>
               <component>
                  <section ID="ID_e10c8548-19a7-401f-9321-c78732a99842">
                     <id root="f1c58927-7d3e-4c10-9a11-dda55324600a"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.1 Monotherapy </title>
                     <text>
                        <paragraph>In a randomized, double-blind, placebo-controlled trial of 24 weeks duration, BYETTA 5 mcg BID (n=77), BYETTA 10 mcg BID (n=78), or placebo BID (n=77) was used as monotherapy in patients with entry HbA1c ranging from 6.5% to 10%. All patients assigned to BYETTA initially received 5 mcg BID for 4 weeks. After 4 weeks, those patients either continued to receive BYETTA 5 mcg BID or had their dose increased to 10 mcg BID. Patients assigned to placebo received placebo BID throughout the trial. BYETTA or placebo was injected subcutaneously before the morning and evening meals. The majority of patients (68%) were White, 26% were West Asian, 3% were Hispanic or Latino ethnicity, 3% were Black or African American, and 0.4% were of East Asian ethnicity.</paragraph>
                        <paragraph>The primary endpoint was the change in HbA<sub>1c</sub> from baseline to Week 24 (or the last value at time of early discontinuation). Compared to placebo, BYETTA 5 mcg BID and 10 mcg BID resulted in statistically significant reductions in HbA<sub>1c</sub> from baseline at Week 24 (Table 7q).</paragraph>
                        <table width="100%">
                           <caption>Table 7: Results of 24-Week Placebo-Controlled Trial of BYETTA used as Monotherapy</caption>
                           <col width="41%"/>
                           <col width="11%"/>
                           <col width="26%"/>
                           <col width="23%"/>
                           <thead>
                              <tr>
                                 <th align="left" styleCode="Rrule Botrule Lrule Toprule " valign="top"/>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">Placebo</content>
                                    <br/>
                                    <content styleCode="bold">BID</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">BYETTA 5 mcg BID</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">BYETTA 10 mcg</content>
                                    <footnote ID="_Ref516121117">BYETTA 5 mcg twice daily (BID) for 1 month followed by 10 mcg BID for 5 months before the morning and evening meals.</footnote>
                                    <br/>
                                    <content styleCode="bold">BID</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Intent-to-Treat Population (N)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>77</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>77</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>78</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">HbA<sub>1c</sub> (%), Mean </content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7.8</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7.9</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7.8</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 24<footnote ID="_Ref516121221">Least squares means are adjusted for screening HbA1c strata and baseline value of the dependent variable.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.2</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.7</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121221"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.5 [â0.9, â0.2]<footnote ID="_Ref516121239">p &lt;0.01, treatment vs. placebo.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.7 [â1.0, â0.3]</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Proportion Achieving HbA<sub>1c</sub> &lt;7%</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>38%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>48%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>53%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Body Weight (kg), Mean </content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>86.1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>85.1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>86.2</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 24<footnoteRef IDREF="_Ref516121221"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â2.7</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â2.9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121221"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.3 [â2.3, â0.2]</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.5 [â2.5, â0.4]</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Fasting Serum Glucose</content>
                                       <footnote ID="_Ref516121303">Measured using the hexokinase-based glucose method.</footnote>
                                       <content styleCode="bold"> (mg/dL), Mean </content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>159</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>166</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>155</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 24<footnoteRef IDREF="_Ref516121221"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â17</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â19</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121221"/> (95% CI) </paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â12 [â23.2, â1.3]</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â14 [â24.5, â2.5]</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Toprule " valign="top">
                                    <paragraph>BID = twice daily.</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>On average, there were no adverse effects of exenatide on blood pressure or lipids.</paragraph>
                     </text>
                     <effectiveTime value="20250528"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_6c57ba33-90da-4e97-9a0b-94b68e591eaf">
                     <id root="2214ff52-dc17-4bcc-a942-c9f0798199fa"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.2 Combination Therapy with Oral Antihyperglycemic Medicines </title>
                     <text>
                        <paragraph>Three 30-week, double-blind, placebo-controlled trials were conducted to evaluate the safety and efficacy of BYETTA in patients with type 2 diabetes whose glycemic control was inadequate with metformin alone, a sulfonylurea alone, or metformin in combination with a sulfonylurea. In addition, a 16-week, placebo-controlled trial was conducted where BYETTA was added to existing thiazolidinedione (pioglitazone or rosiglitazone) treatment, with or without metformin, in patients with type 2 diabetes with inadequate glycemic control.</paragraph>
                        <paragraph>In the 30-week trials, after a 4-week placebo lead-in period, patients were randomly assigned to receive BYETTA 5 mcg BID, BYETTA 10 mcg BID, or placebo BID before the morning and evening meals, in addition to their existing oral antidiabetic agent. All patients assigned to BYETTA initially received 5 mcg BID for 4 weeks. After 4 weeks, those patients either continued to receive BYETTA 5 mcg BID or had their dose increased to 10 mcg BID. Patients assigned to placebo received placebo BID throughout the study. A total of 1446 patients were randomized in the three 30-week trials: 991 (69%) were White, 224 (16%) were Hispanic or Latino and 174 (12%) were of Black of African American ethnicity. Mean HbA1c values at baseline for the trials ranged from 8.2% to 8.7%.</paragraph>
                        <paragraph>In the placebo-controlled trial of 16 weeks duration, BYETTA (n=121) or placebo (n=112) was added to existing thiazolidinedione (pioglitazone or rosiglitazone) treatment, with or without metformin. Randomization to BYETTA or placebo was stratified based on whether the patients were receiving metformin. BYETTA treatment was initiated at a dose of 5 mcg BID for 4 weeks then increased to 10 mcg BID for 12 more weeks. Patients assigned to placebo received placebo BID throughout the study. BYETTA or placebo was injected subcutaneously before the morning and evening meals. In this trial, 79% of patients were taking a thiazolidinedione and metformin and 21% were taking a thiazolidinedione alone. The majority of patients (84%) were White, 8% were Hispanic or Latino ethnicity, and 3% were of Black or African American ethnicity. The mean baseline HbA1c values were 7.9% for BYETTA and placebo. </paragraph>
                        <paragraph>The primary endpoint in each study was the mean change in HbA<sub>1c</sub> from baseline to study end (or early discontinuation). Table 8 summarizes the study results for the 30- and 16-week clinical trials.</paragraph>
                        <table width="100%">
                           <caption>Table 8: Results of 30-Week and 16-Week Placebo-Controlled Trials of BYETTA used in Combination with Oral Antidiabetic Agents</caption>
                           <col width="32%"/>
                           <col width="14%"/>
                           <col width="27%"/>
                           <col width="28%"/>
                           <thead>
                              <tr>
                                 <th align="left" styleCode="Rrule Botrule Lrule Toprule " valign="top"/>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">Placebo</content>
                                    <br/>
                                    <content styleCode="bold">BID</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">BYETTA 5 mcg</content>
                                    <br/>
                                    <content styleCode="bold">BID</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">BYETTA 10 mcg</content>
                                    <footnote ID="_Ref516121817">BYETTA 5 mcg twice daily for 1 month followed by 10 mcg BID for 6 months for the 30-week trials or 10 mcg BID for 3 months in the 16-week trial before the morning and evening meals.</footnote>
                                    <br/>
                                    <content styleCode="bold">BID</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top"/>
                                 <td align="center" colspan="3" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">In Combination with Metformin (30 Weeks)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Intent-to-Treat Population (N)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>113</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>110</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>113</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">HbA<sub>1c</sub> (%), Mean</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8.2</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8.3</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8.2</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 30<footnote ID="_Ref516121884">Least squares means are adjusted for baseline HbA<sub>1c</sub> strata or value, investigator site, baseline value of the dependent variable (if applicable), and background antihyperglycemic therapy (if applicable).</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.5 [â0.7, â0.2]<footnote ID="_Ref516122025">p &lt;0.01, treatment vs. placebo.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.9 [â1.1, â0.6]<footnoteRef IDREF="_Ref516122025"/>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Proportion Achieving HbA<sub>1c</sub> &lt;7%</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>12%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>32%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>40%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Body Weight (kg), Mean </content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>99.9</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>100.0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>100.9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 30<footnoteRef IDREF="_Ref516121884"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.2</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.3</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â2.6</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.1 [â2.2, â0.0]</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â2.4 [â3.5, â1.3]</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Fasting Plasma Glucose</content>
                                       <footnote ID="_Ref516122108">Measured using the hexokinase-based glucose method.</footnote>
                                       <content styleCode="bold">
                                          <content styleCode="italics"/> (mg/dL), Mean</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>169</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>176</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>168</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 30<footnoteRef IDREF="_Ref516121884"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>+14</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â10</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â20 [â32, â7]</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â24 [â37, â12]</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top"/>
                                 <td align="center" colspan="3" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">In Combination with a Sulfonylurea (30 Weeks)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Intent-to-Treat Population (N)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>123</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>125</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>129</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">HbA<sub>1c</sub> (%), Mean</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8.7</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8.5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8.6</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 30<footnoteRef IDREF="_Ref516121884"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>+0.1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.6 [â0.9, â0.3]<footnoteRef IDREF="_Ref516122025"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.0 [â1.3, â0.7]<footnoteRef IDREF="_Ref516122025"/>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Proportion Achieving HbA<sub>1c</sub> &lt;7%</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>10%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>25%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>36%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Body Weight (kg), Mean</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>99.1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>94.9</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>95.2</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 30<footnoteRef IDREF="_Ref516121884"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.8</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.6</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.3 [â1.1, 0.6]</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.9 [â1.7, â0.0]</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Fasting Plasma Glucose</content>
                                       <footnoteRef IDREF="_Ref516122108"/>
                                       <content styleCode="bold"> (mg/dL), Mean</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>194</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>180</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>178</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 30<footnoteRef IDREF="_Ref516121884"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>+6</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â11</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â11 [â25, 3]</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â17 [â30, â3]</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top"/>
                                 <td align="center" colspan="3" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">In Combination with Metformin and a Sulfonylurea (30 Weeks)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Intent-to-Treat Population (N)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>247</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>245</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>241</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">HbA<sub>1c</sub> (%), Mean</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8.5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8.5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8.5</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 30<footnoteRef IDREF="_Ref516121884"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>+0.1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.7</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.8 [â1.0, â0.6]<footnoteRef IDREF="_Ref516122025"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.0 [â1.2, â0.8]<footnoteRef IDREF="_Ref516122025"/>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Proportion Achieving HbA<sub>1c</sub> &lt;7%</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>25%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>31%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Body Weight (kg), Mean</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>99.1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>96.9</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>98.4</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 30<footnoteRef IDREF="_Ref516121884"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.9</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.6</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.6</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.7 [â1.2, â0.2]</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.7 [â1.3, â0.2]</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Fasting Plasma Glucose</content>
                                       <footnoteRef IDREF="_Ref516122108"/>
                                       <content styleCode="bold"> (mg/dL), Mean</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>181</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>182</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>178</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 30<footnoteRef IDREF="_Ref516121884"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>+13</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â11</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â12</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â24 [â33, â15]</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â25 [â34, â16]</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top"/>
                                 <td align="center" colspan="3" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">In Combination with a Thiazolidinedione or a Thiazolidinedione plus Metformin (16 Weeks)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Intent-to-Treat Population (N)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>112</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dose not studied</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>121</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">HbA<sub>1c</sub> (%), Mean</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7.9</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dose not studied</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7.9</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 16<footnoteRef IDREF="_Ref516121884"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>+0.1</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dose not studied</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.7</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dose not studied</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.9 [â1.1, â0.7]<footnoteRef IDREF="_Ref516122025"/>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Proportion Achieving HbA<sub>1c</sub> &lt;7%</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>15%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dose not studied</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>51%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Body Weight (kg), Mean</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>96.8</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dose not studied</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>97.5</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 16<footnoteRef IDREF="_Ref516121884"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â0.0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dose not studied</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.5</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dose not studied</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â1.5 [â2.2, â0.7]</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Fasting Serum Glucose</content>
                                       <footnoteRef IDREF="_Ref516122108"/>
                                       <content styleCode="bold"> (mg/dL), Mean</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Baseline</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>159</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dose not studied</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>164</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Change at Week 16<footnoteRef IDREF="_Ref516121884"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>+4</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dose not studied</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â21</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516121884"/> (95% CI)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dose not studied</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>â25 [â33, â16]</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Toprule " valign="top">
                                    <paragraph>BID = twice daily.</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20250528"/>
                     <component>
                        <section ID="ID_7f92207b-5642-41f7-b643-12d68a8c9c52">
                           <id root="34bfbf86-583b-4f6c-a55f-3b06be517988"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <title>
                              <content styleCode="bold">HbA<sub>1c </sub>
                              </content>
                           </title>
                           <text>
                              <paragraph>The addition of BYETTA to a regimen of metformin, a sulfonylurea, or both, resulted in statistically significant reductions from baseline in HbA<sub>1c</sub> compared with patients receiving placebo added to these agents in the three controlled trials (Table 8).</paragraph>
                              <paragraph>In the 16-week trial of BYETTA add-on to thiazolidinediones, with or without metformin, BYETTA resulted in statistically significant reductions from baseline in HbA<sub>1c</sub> compared with patients receiving placebo (Table 8).</paragraph>
                           </text>
                           <effectiveTime value="20250528"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_8d96c95d-eb99-4b64-80db-c1e9eb5512b7">
                           <id root="8d96c95d-eb99-4b64-80db-c1e9eb5512b7"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <title>
                              <content styleCode="bold">Postprandial Glucose</content>
                           </title>
                           <text>
                              <paragraph>Postprandial glucose was measured after a mixed meal tolerance test in 9.5% of patients participating in the 30-week add-on to metformin, add-on to sulfonylurea, and add-on to metformin in combination with sulfonylurea clinical trials. In this pooled subset of patients, BYETTA reduced postprandial plasma glucose concentrations in a dose-dependent manner. The mean (SD) change in 2-hour postprandial glucose concentration following administration of BYETTA at Week 30 relative to baseline was <content styleCode="bold">â</content>63 (65) mg/dL for 5 mcg BID (n=42), <content styleCode="bold">â</content>71 (73) mg/dL for 10 mcg BID (n=52), and +11 (69) mg/dL for placebo BID (n=44).</paragraph>
                           </text>
                           <effectiveTime value="20141211"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="ID_9c1a43c8-b946-4557-a533-98fb3b54b94c">
                     <id root="573da6a0-5e88-4ea4-8326-f0efc91ac539"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.3 Combination with Insulin Glargine </title>
                     <effectiveTime value="20250528"/>
                     <component>
                        <section ID="ID_3924d3bc-530f-4108-8062-afc90fd5259c">
                           <id root="258cc872-f845-4f33-8b1c-63a2b6cf22ee"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <title>
                              <content styleCode="bold">30-Week Placebo-Controlled Trial</content>
                           </title>
                           <text>
                              <paragraph>A 30-week, double-blind, placebo-controlled trial was conducted to evaluate the efficacy and safety of BYETTA (n=137) versus placebo (n=122) when added to titrated insulin glargine, with or without metformin and/or thiazolidinedione, in patients with type 2 diabetes with inadequate glycemic control.</paragraph>
                              <paragraph>All patients assigned to BYETTA initially received 5 mcg BID for 4 weeks. After 4 weeks, those patients assigned to BYETTA had their dose increased to 10 mcg BID. Patients assigned to placebo received placebo BID throughout the trial. BYETTA or placebo was injected subcutaneously before the morning and evening meals. Patients with an HbA1c â¤8.0% decreased their prestudy dose of insulin glargine by 20% and patients with an HbA1c â¥8.1% maintained their current dose of insulin glargine. Five weeks after initiating randomized treatment, insulin doses were titrated with guidance from the investigator toward predefined fasting glucose targets according to the dose titration algorithm provided in Table 9. The majority of patients (78%) were White, 10% were American Indian or Alaska Native, 9% were Black or African American, 3% were Asian, and 0.8% were of multiple origins.</paragraph>
                              <paragraph>The primary endpoint was the change in HbA1c from baseline to Week 30. Compared to placebo, BYETTA 10 mcg BID resulted in statistically significant reductions in HbA1c from baseline at Week 30 (Table 9) in patients receiving titrated insulin glargine.</paragraph>
                              <table width="100%">
                                 <caption>Table 9: 30-Week Placebo-Controlled Trial of BYETTA Used in Combination with Insulin Glargine with or without Metformin and/or Thiazolidinediones</caption>
                                 <col width="40%"/>
                                 <col width="30%"/>
                                 <col width="30%"/>
                                 <thead>
                                    <tr>
                                       <th align="left" styleCode="Rrule Botrule Lrule Toprule " valign="top"/>
                                       <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                          <content styleCode="bold">Placebo BID</content>
                                          <br/>
                                          <content styleCode="bold">+</content>
                                          <br/>
                                          <content styleCode="bold">Titrated Insulin Glargine</content>
                                       </th>
                                       <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                          <content styleCode="bold">BYETTA 10 mcg</content>
                                          <footnote ID="_Ref516122889">BYETTA 5 mcg twice daily for 1 month followed by 10 mcg BID for 5 months for the 30-week trial.</footnote>
                                          <content styleCode="bold">
                                             <content styleCode="italics"/> BID</content>
                                          <br/>
                                          <content styleCode="bold">+</content>
                                          <br/>
                                          <content styleCode="bold">Titrated Insulin Glargine</content>
                                       </th>
                                    </tr>
                                 </thead>
                                 <tbody>
                                    <tr>
                                       <td styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">Intent-to-Treat Population (N)</content>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>122</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>137</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">HbA<sub>1c</sub> (%), Mean </content>
                                          </paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>Â Â Baseline</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>8.5</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>8.3</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>Â Â Change at Week 30<footnote ID="_Ref516122935">Least squares means are based on a mixed model adjusting for treatment, pooled investigator, visit, baseline HbA<sub>1c</sub> value, and treatment by visit, where subject is treated as a random effect.</footnote>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â1.0</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â1.7</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516122935"/> (95% CI)</paragraph>
                                       </td>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â0.7 [â1.0, â0.5]<footnote ID="_Ref516122981">p &lt;0.01, treatment vs. placebo.</footnote>
                                          </paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">Proportion Achieving HbA<sub>1c</sub> &lt;7%</content>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>29%</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>56%</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">Body Weight (kg), Mean </content>
                                          </paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>Â Â Baseline</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>93.8</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>95.4</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>Â Â Change at Week 30<footnote ID="_Ref516123017">Least squares means are based on a mixed model adjusting for treatment, pooled investigator, visit, baseline HbA<sub>1c</sub> stratum, baseline value of the dependent variable (where applicable), and treatment by visit, where subject is treated as a random effect.</footnote>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>1.0</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â1.8</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516123017"/> (95% CI)</paragraph>
                                       </td>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â2.7 [â3.7, â1.7]<footnoteRef IDREF="_Ref516122981"/>
                                          </paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">Fasting Serum Glucose</content>
                                             <footnote ID="_Ref516123168">Patients in both groups titrated insulin glargine dose to achieve optimal fasting glucose concentrations.</footnote>
                                             <content styleCode="bold"> (mg/dL), Mean</content>
                                          </paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>Â Â Baseline</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>133</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>132</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>Â Â Change at Week 30<footnoteRef IDREF="_Ref516123017"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â16</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â23</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>Â Â Difference from placebo<footnoteRef IDREF="_Ref516123017"/> (95% CI)</paragraph>
                                       </td>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â7 [â18, 3]</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td colspan="3" valign="top">
                                          <paragraph>BID = twice daily.</paragraph>
                                       </td>
                                    </tr>
                                 </tbody>
                              </table>
                              <table width="100%">
                                 <caption>Table 10: Dosing Algorithm for Titration of Insulin Glargine<footnote ID="_Ref72924364">Adapted from Riddle et al. 2003.</footnote>
                                 </caption>
                                 <col width="69%"/>
                                 <col width="31%"/>
                                 <tbody>
                                    <tr>
                                       <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">Fasting Plasma Glucose Values</content>
                                             <br/>
                                             <content styleCode="bold">(mg/dL)</content>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">Dose Change</content>
                                             <br/>
                                             <content styleCode="bold">(U)</content>
                                          </paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>&lt;56<footnote ID="_Ref516123333">Value for at least 1 fasting plasma glucose measurement since the last assessment.</footnote>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">â</content>4</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>56 to 72<footnoteRef IDREF="_Ref516123333"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">â</content>2</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>73 to 99<footnote ID="_Ref516123353">Based on the average of fasting plasma glucose measurements taken over the prior 3 to 7 days. The increase in the total daily dose should not have exceeded more than 10 units per day or 10% of the current total daily dose, whichever was greater.</footnote>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>0</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>100 to 119<footnoteRef IDREF="_Ref516123353"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>+2</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>120 to 139<footnoteRef IDREF="_Ref516123353"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>+4</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>140 to 179<footnoteRef IDREF="_Ref516123353"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>+6</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                          <paragraph>â¥180<footnoteRef IDREF="_Ref516123353"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>+8</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td colspan="2" valign="top">
                                          <paragraph>Abbreviations: U = units.</paragraph>
                                       </td>
                                    </tr>
                                 </tbody>
                              </table>
                           </text>
                           <effectiveTime value="20250528"/>
                        </section>
                     </component>
                     <component>
                        <section ID="ID_3215fb36-8263-4f89-a65e-c55723a5ec60">
                           <id root="ea3a2108-4a3d-45c5-9879-c8ee75e386b7"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <title>
                              <content styleCode="bold">30-Week Comparator-Controlled Noninferiority Trial</content>
                           </title>
                           <text>
                              <paragraph>A 30 week, open-label, active comparator-controlled, noninferiority study was conducted to evaluate the safety and efficacy of BYETTA (n=315) versus titrated insulin lispro (n=312) on a background of optimized basal insulin glargine and metformin in patients with type 2 diabetes with inadequate glycemic control.</paragraph>
                              <paragraph>Following a 12-week basal insulin optimization (BIO) phase, subjects with an HbA<sub>1c</sub> &gt;7.0% entered a 30-week intervention phase and were randomized to add either BYETTA or insulin lispro to their existing regimen of insulin glargine and metformin. Insulin glargine was titrated to a target fasting plasma glucose of 72 to 100 mg/dL.</paragraph>
                              <paragraph>All patients assigned to BYETTA initially received 5 mcg BID for four weeks. After four weeks, their dose was increased to 10 mcg BID. Patients in the BYETTA-treated arm with an HbA<sub>1c</sub> â¤8.0% at the end of the BIO phase decreased their insulin glargine dose by at least 10%.</paragraph>
                              <paragraph>All patients assigned to insulin lispro three times daily (TID) maintained their prior total daily insulin dose at baseline; however, the initial insulin lispro dose was â to Â½ of the total daily insulin dose with the insulin glargine dose reduced accordingly. The insulin lispro dose was titrated based on preprandial glucose values.</paragraph>
                              <paragraph>The majority of patients (87%) were White, 7% were American Indian or Alaska Native, 5% were Asian, and &lt;1% were of Black or African American ethnicity.</paragraph>
                              <paragraph>The primary endpoint was the change in HbA<sub>1c</sub> from baseline to Week 30. Both BYETTA 10 mcg BID and titrated lispro provided a mean reduction in HbA<sub>1c</sub> at Week 30 that met the pre-specified non-inferiority margin of 0.4%.</paragraph>
                              <table width="100%">
                                 <caption>Table 11: 30-Week Comparator-Controlled Trial of BYETTA used in Combination with Insulin Glargine and Metformin</caption>
                                 <col width="38%"/>
                                 <col width="29%"/>
                                 <col width="33%"/>
                                 <tbody>
                                    <tr>
                                       <td styleCode="Rrule Botrule Lrule Toprule " valign="top"/>
                                       <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">Titrated Insulin Lispro TID</content>
                                          </paragraph>
                                          <paragraph>
                                             <content styleCode="bold">+</content>
                                          </paragraph>
                                          <paragraph>
                                             <content styleCode="bold">Titrated Insulin Glargine</content>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">BYETTA 10 mcg<footnote ID="_Ref516123408">BYETTA 5 mcg BID for 1 month followed by 10 mcg BID for 5 months for the 30-week trial.</footnote> BID</content>
                                          </paragraph>
                                          <paragraph>
                                             <content styleCode="bold">+</content>
                                          </paragraph>
                                          <paragraph>
                                             <content styleCode="bold">Titrated Insulin Glargine</content>
                                          </paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">Intent-to-Treat Population (N)</content>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>312</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>315</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td colspan="3" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">HbA<sub>1c</sub> (%), Mean</content>
                                          </paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>Â Â Â Baseline</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>8.2</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>8.3</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>Â Â Â Change at Week 30<footnote ID="_Ref516123458">Least squares means are based on a mixed model adjusting for treatment, country, prior use of sulfonylurea (yes/no), visit, corresponding baseline, and treatment by visit interaction, where subject is treated as a random effect.</footnote>
                                             <footnote ID="_Ref516123523">Data at 30 weeks are available from 88% and 84% of the intent-to-treat subjects in the Lispro and BYETTA groups, respectively.</footnote>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â1.1</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â1.1</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>Â Â Â Difference from Insulin Lispro<footnoteRef IDREF="_Ref516123458"/>
                                             <footnoteRef IDREF="_Ref516123523"/> (95% CI)</paragraph>
                                       </td>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â0.0 [â0.2, 0.1]</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td colspan="3" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">Body Weight (kg), Mean</content>
                                          </paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>Â Â Â Baseline</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>89.3</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>89.9</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>Â Â Â Change at Week 30<footnoteRef IDREF="_Ref516123458"/>
                                             <footnoteRef IDREF="_Ref516123523"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>1.9</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â2.6</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>Â Â Â Difference from Insulin Lispro<footnoteRef IDREF="_Ref516123458"/>
                                             <footnoteRef IDREF="_Ref516123523"/> (95% CI)</paragraph>
                                       </td>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â4.5 [â5.2, â3.9]</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td colspan="3" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>
                                             <content styleCode="bold">Fasting Serum Glucose</content>
                                             <footnote ID="_Ref516123575">Patients titrated insulin glargine or insulin lispro dose to achieve prespecified target fasting and preprandial glucose concentrations.</footnote>
                                             <content styleCode="bold">
                                                <content styleCode="italics"/>(mg/dL), Mean</content>
                                          </paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>Â Â Â Baseline</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>126</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>130</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>Â Â Â Change at Week 30<footnoteRef IDREF="_Ref516123458"/>
                                             <footnoteRef IDREF="_Ref516123523"/>
                                          </paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>5</paragraph>
                                       </td>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â7</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>Â Â Â Difference from Insulin Lispro<footnoteRef IDREF="_Ref516123458"/>
                                             <footnoteRef IDREF="_Ref516123523"/> (95% CI)</paragraph>
                                       </td>
                                       <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                       <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                          <paragraph>â12 [â19, â4]</paragraph>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td colspan="3" styleCode="Rrule Toprule " valign="top">
                                          <paragraph>BID = twice daily.</paragraph>
                                          <paragraph>TID = three times daily.</paragraph>
                                       </td>
                                    </tr>
                                 </tbody>
                              </table>
                           </text>
                           <effectiveTime value="20250528"/>
                        </section>
                     </component>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S16">
               <id root="5fc4088f-501f-4fad-aff3-ff6c05493410"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING</title>
               <effectiveTime value="20241101"/>
               <component>
                  <section ID="S16.1">
                     <id root="6a19135b-b86b-4faa-b476-4b0f576b41ee"/>
                     <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
                     <title>16.1 How Supplied</title>
                     <text>
                        <paragraph>BYETTA (exenatide) 250 mcg/mL is a clear, colorless solution supplied as:</paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>5 mcg per dose, 60 doses, 1.2 mL prefilled pen, NDC 0310-6512-01</item>
                           <item>
                              <caption>â¢</caption>10 mcg per dose, 60 doses, 2.4 mL prefilled pen, NDC 0310-6524-01</item>
                        </list>
                     </text>
                     <effectiveTime value="20221221"/>
                  </section>
               </component>
               <component>
                  <section ID="S16.2">
                     <id root="cd687e96-fcc6-4643-850e-37262f1869d3"/>
                     <code code="44425-7" codeSystem="2.16.840.1.113883.6.1" displayName="STORAGE AND HANDLING SECTION"/>
                     <title>16.2 Storage and Handling</title>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>â¢</caption>Store BYETTA in the refrigerator at 36Â°F to 46Â°F (2Â°C to 8Â°C).</item>
                           <item>
                              <caption>â¢</caption>After first use, BYETTA can be kept at a temperature not to exceed 77Â°F (25Â°C).</item>
                           <item>
                              <caption>â¢</caption>Do not freeze. Do not use BYETTA if it has been frozen.</item>
                           <item>
                              <caption>â¢</caption>Protect BYETTA from light.</item>
                           <item>
                              <caption>â¢</caption>Discard the pen 30 days after first use, even if some drug remains in the pen.</item>
                           <item>
                              <caption>â¢</caption>Use a puncture-resistant container to discard the needles. Do not reuse or share needles.</item>
                        </list>
                     </text>
                     <effectiveTime value="20241101"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="S17">
               <id root="82ee9664-a24d-4af1-9955-f5c75a7e276b"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17 PATIENT COUNSELING INFORMATION</title>
               <text>
                  <paragraph>Advise the patient to read the FDA-approved patient labeling (Medication Guide and Instructions for Use).</paragraph>
                  <paragraph>
                     <content styleCode="italics">Acute Pancreatitis </content>
                  </paragraph>
                  <paragraph>Inform patients of the potential risk for acute pancreatitis and its symptoms: severe abdominal pain that may  radiate to the back, and which may or may not be accompanied by vomiting. Instruct patients to discontinue  BYETTA promptly and contact their physician if pancreatitis is suspected<content styleCode="italics"> [see <linkHtml href="#S5.1">Warnings and Precautions (5.1)</linkHtml>].</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="italics">Never Share a BYETTA Pen Between Patients </content>
                  </paragraph>
                  <paragraph>Advise patients that they must never share a BYETTA pen with another person, even if the needle is changed, because doing so carries a risk for transmission of blood-borne pathogens<content styleCode="italics"> [see <linkHtml href="#S5.2">Warnings and Precautions (5.2)</linkHtml>].</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="italics">Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin </content>
                  </paragraph>
                  <paragraph>Inform patients that the risk of hypoglycemia is increased when BYETTA is used in combination with an agent that induces hypoglycemia, such as a sulfonylurea or insulin. Educate patients on the signs and symptoms of hypoglycemia<content styleCode="italics"> [see <linkHtml href="#S5.3">Warnings and Precautions (5.3)</linkHtml>].</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="italics">Acute Kidney Injury Due to Volume Depletion</content>
                  </paragraph>
                  <paragraph>Inform patients of the potential risk of acute kidney injury due to dehydration associated with gastrointestinal adverse reactions. Advise patients to take precautions to avoid fluid depletion. Inform patients of the signs and symptoms of acute kidney injury and instruct them to promptly report any of these signs or symptoms or persistent (or extended) nausea, vomiting, and diarrhea to their healthcare provider<content styleCode="italics"> [see <linkHtml href="#S5.4">Warnings and Precautions (5.4)</linkHtml>].</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="italics">Severe Gastrointestinal Adverse Reactions</content>
                  </paragraph>
                  <paragraph>Inform patients of the potential risk of severe gastrointestinal adverse reactions. Instruct patients to contact their healthcare provider if they have severe or persistent gastrointestinal symptoms<content styleCode="italics"> [see <linkHtml href="#S5.5">Warnings and Precautions (5.5)</linkHtml>].</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="italics">Drug-Induced Thrombocytopenia </content>
                  </paragraph>
                  <paragraph>Inform patients that drug-induced immune mediated thrombocytopenia has been reported during use of exenatide. Inform patients that if symptoms of thrombocytopenia occur, stop taking BYETTA and seek medical advice promptly<content styleCode="italics"> [see <linkHtml href="#S5.8">Warnings and Precautions (5.8)</linkHtml>].</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="italics">Hypersensitivity Reactions </content>
                  </paragraph>
                  <paragraph>Inform patients that serious hypersensitivity reactions have been reported during postmarketing use of BYETTA. If symptoms of hypersensitivity reactions occur, instruct patients to stop taking BYETTA and seek medical advice promptly<content styleCode="italics"> [see <linkHtml href="#S5.7">Warnings and Precautions (5.7)</linkHtml>].</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="italics">Acute Gallbladder Disease </content>
                  </paragraph>
                  <paragraph>Inform patients of the potential risk for cholelithiasis or cholecystitis. Instruct patients to contact their physician if cholelithiasis or cholecystitis is suspected for appropriate clinical follow-up<content styleCode="italics"> [see <linkHtml href="#ID_b2273663-5dc6-4684-8c17-62f4a2521929">Warnings and Precautions (5.9)</linkHtml>].</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="italics">Pulmonary Aspiration During General Anesthesia or Deep Sedation </content>
                  </paragraph>
                  <paragraph>Inform patients that BYETTA may cause their stomach to empty more slowly which may lead to complications with anesthesia or deep sedation during planned surgeries or procedures. Instruct patients to inform healthcare providers prior to any planned surgeries or procedures if they are taking BYETTA<content styleCode="italics"> [see <linkHtml href="#ID_bf76a419-898f-457f-9de6-018ca84f6012">Warnings and Precautions (5.10)</linkHtml>].</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="italics">Pregnancy</content>
                  </paragraph>
                  <paragraph>Advise patients to inform their physicians if they are pregnant or intend to become pregnant.</paragraph>
                  <paragraph>
                     <content styleCode="italics">Instructions</content>
                  </paragraph>
                  <paragraph>Instruct patients to administer BYETTA as a subcutaneous injection in the thigh, abdomen, or upper arm at any time within the 60-minute period before the morning and evening meals (or before the two main meals of the day, approximately 6 hours or more apart). Do not administer BYETTA after a meal. If a dose is missed, resume the treatment regimen as prescribed with the next scheduled dose.Â </paragraph>
                  <paragraph>Â Distributed by:<br/>AstraZeneca Pharmaceuticals LP<br/>Wilmington, DE 19850</paragraph>
                  <paragraph>BYETTA<sup>Â®</sup> is a registered trademark of the AstraZeneca group of companies.</paragraph>
               </text>
               <effectiveTime value="20250528"/>
            </section>
         </component>
         <component>
            <section ID="MG">
               <id root="00d2bb7a-6dbb-49a1-a543-114b38f387e9"/>
               <code code="42231-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL MEDGUIDE SECTION"/>
               <text>
                  <table width="100%">
                     <col width="100%"/>
                     <tbody>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">MEDICATION GUIDE</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">BYETTAÂ® (bye-A-tuh)</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">(exenatide)</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">injection, for subcutaneous use</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>Read this Medication Guide and the Instructions for Use that comes with BYETTA before you start using it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking with your healthcare provider about your medical condition or your treatment. If you have questions about BYETTA after reading this information, ask your healthcare provider or pharmacist.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What is the most important information I should know about BYETTA?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Serious side effects can happen in people who take BYETTA, including inflammation of your pancreas (pancreatitis). Stop using BYETTA and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What is BYETTA?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>BYETTA is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. </item>
                                 <item>
                                    <caption>â¢</caption>BYETTA is not recommended for people who take exenatide or other medicines called glucagon-like peptide 1 (GLP-1) receptor agonist.</item>
                                 <item>
                                    <caption>â¢</caption>It is not known if BYETTA is safe and effective in children.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Who should not use BYETTA?</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Do not use BYETTA if:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>you have had a severe allergic reaction to exenatide or any of the other ingredients in BYETTA. See the end of this Medication Guide for a complete list of ingredients in BYETTA. See â<content styleCode="bold">What are the possible side effects of BYETTA?</content>â for symptoms of a serious allergic reaction.</item>
                                 <item>
                                    <caption>â¢</caption>you have a history of low blood platelet count from using exenatide medicines (drug-induced thrombocytopenia).</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top"/>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Before taking BYETTA, tell your healthcare provider about all of your medical conditions, including if you:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>have or have had problems with your pancreas.</item>
                                 <item>
                                    <caption>â¢</caption>have severe problems with your stomach, such as delayed emptying of your stomach (gastroparesis) or problems with digesting food.</item>
                                 <item>
                                    <caption>â¢</caption>are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation).</item>
                                 <item>
                                    <caption>â¢</caption>are pregnant or plan to become pregnant. It is not known if BYETTA will harm your unborn baby. Tell your healthcare provider if you become pregnant while taking BYETTA. Talk to your healthcare provider about the best way to control your blood sugar if you plan to become pregnant or while you are pregnant.</item>
                                 <item>
                                    <caption>â¢</caption>are breastfeeding or plan to breastfeed. It is not known if BYETTA passes into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while taking BYETTA. </item>
                              </list>
                              <paragraph>Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. BYETTA may affect the way some medicines work and some other medicines may affect the way BYETTA works.</paragraph>
                              <paragraph>
                                 <content styleCode="bold">Before using BYETTA, talk to your healthcare provider about low blood sugar and how to manage it.</content> Tell your healthcare provider if you are taking other medicines to treat diabetes, including insulin or sulfonylureas.</paragraph>
                              <paragraph>Especially tell your healthcare provider if you take:</paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>birth control pills that are taken by mouth (oral contraceptives). BYETTA may lower the amount of the medicine in your blood from your birth control pills and they may not work as well to prevent pregnancy. Take your birth control pills at least one hour before your injection of BYETTA. If you must take your birth control pills with food, take it with a meal or snack at a time when you do not also take BYETTA.</item>
                                 <item>
                                    <caption>â¢</caption>antibiotics. Take antibiotic medicines at least one hour before taking BYETTA. If you must take your antibiotic with food, take it with a meal or snack at a time when you do not also take BYETTA.</item>
                                 <item>
                                    <caption>â¢</caption>warfarin </item>
                                 <item>
                                    <caption>â¢</caption>lovastatin </item>
                              </list>
                              <paragraph>Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">How should I take BYETTA?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Read the Instructions for Use that comes with BYETTA. </item>
                                 <item>
                                    <caption>â¢</caption>Use BYETTA exactly as your healthcare provider tells you to. </item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Your healthcare provider should teach you how to inject BYETTA before you use it for the first time. </content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>Inject your dose of BYETTA under the skin (subcutaneous injection) of your upper leg (thigh), stomach area (abdomen), or upper arm as instructed by your healthcare provider. Do not inject into a muscle (intramuscularly) or vein (intravenously).</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Inject BYETTA</content> two times each day, at any time within 60 minutes (1 hour) <content styleCode="bold">before</content> your morning and evening meals (or <content styleCode="bold">before</content> the two main meals of the day, approximately 6 hours or more apart). <content styleCode="bold">Do not take BYETTA after your meal.</content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>If you miss a dose of BYETTA, skip that dose and take your next dose at the next prescribed time. Do not take an extra dose or increase the amount of your next dose to make up for a missed dose.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Do not</content> mix insulin and BYETTA together in the same injection.</item>
                                 <item>
                                    <caption>â¢</caption>You may give an injection of BYETTA and insulin in the same body area (such as your stomach area), but not right next to each other.</item>
                                 <item>
                                    <caption>â¢</caption>Change (rotate) your injection sites within the area you chose with each dose. <content styleCode="bold">Do not </content>use the same spot for each injection.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Do not share your BYETTA pen with other people, even if the needle has been changed.</content> You may give other people a serious infection or get a serious infection from them.</item>
                                 <item>
                                    <caption>Â </caption>If you take too much BYETTA, call your healthcare provider or Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What are the possible side effects of BYETTA?</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">BYETTA may cause serious side effects, including: </content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>See <content styleCode="bold">"What is the most important information I should know about BYETTA?"</content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">low blood sugar (hypoglycemia)</content>. Your risk for getting low blood sugar is higher if you take BYETTA with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin.</item>
                                 <item>
                                    <caption>â¢</caption> Signs and symptoms of low blood sugar may include:<list listType="unordered">
                                       <item>
                                          <caption>â</caption>dizziness or light-headedness</item>
                                       <item>
                                          <caption>â</caption>sweating</item>
                                       <item>
                                          <caption>â</caption>confusion or drowsiness</item>
                                       <item>
                                          <caption>â</caption>headache</item>
                                       <item>
                                          <caption>â</caption>blurred vision</item>
                                       <item>
                                          <caption>â</caption>slurred speech</item>
                                       <item>
                                          <caption>â</caption>shakiness</item>
                                       <item>
                                          <caption>â</caption>fast heartbeat</item>
                                       <item>
                                          <caption>â</caption>anxiety, irritability, or mood changes</item>
                                       <item>
                                          <caption>â</caption>hunger</item>
                                       <item>
                                          <caption>â</caption>weakness</item>
                                    </list>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>feeling jittery</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">dehydration leading to kidney problems</content>.Â Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">severe stomach problems.</content> Stomach problems, sometimes severe, have been reported in people who use BYETTA. Tell your healthcare provider if you have stomach problems that are severe or will not go away.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">low blood platelet count (drug-induced thrombocytopenia).</content> BYETTA may cause the number of platelets in your blood to be reduced. When your platelet count is too low, your body cannot form blood clots. You could have serious bleeding that could lead to death. <content styleCode="bold">Stop using BYETTA and call your healthcare provider right away if you have unusual bleeding or bruising.</content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">severe allergic reactions.</content> Stop taking BYETTA and get medical help right away if you have any symptom of a severe allergic reaction including:<list listType="unordered">
                                       <item>
                                          <caption>â</caption>swelling of your face, lips, tongue or throat</item>
                                       <item>
                                          <caption>â</caption>problems breathing or swallowing</item>
                                       <item>
                                          <caption>â</caption>severe rash or itching</item>
                                       <item>
                                          <caption>â</caption>fainting or feeling dizzy</item>
                                       <item>
                                          <caption>â</caption>very rapid heartbeat</item>
                                    </list>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">gallbladder problems.</content> Gallbladder problems have happened in some people who take BYETTA. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include:<list listType="unordered">
                                       <item>
                                          <caption>â</caption>pain in your upper stomach (abdomen)</item>
                                       <item>
                                          <caption>â</caption>yellowing of skin or eyes (jaundice)</item>
                                       <item>
                                          <caption>â</caption>fever</item>
                                       <item>
                                          <caption>â</caption>clay-colored stools</item>
                                    </list>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). </content>BYETTA may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking BYETTA before you are scheduled to have surgery or other procedures.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">The most common side effects of BYETTA include:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>Â </caption>
                                    <list listType="unordered">
                                       <item>
                                          <caption>â</caption>nausea</item>
                                       <item>
                                          <caption>â</caption>feeling jittery </item>
                                       <item>
                                          <caption>â</caption>indigestion</item>
                                       <item>
                                          <caption>â</caption>vomiting</item>
                                       <item>
                                          <caption>â</caption>dizziness</item>
                                       <item>
                                          <caption>â</caption>constipation</item>
                                       <item>
                                          <caption>â</caption>diarrhea</item>
                                       <item>
                                          <caption>â</caption>headache</item>
                                       <item>
                                          <caption>â</caption>weakness</item>
                                    </list>
                                 </item>
                              </list>
                              <paragraph>Talk to your healthcare provider about any side effect that bothers you or that does not go away. These are not all the possible side effects of BYETTA.</paragraph>
                              <paragraph>Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule " valign="top"/>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top"/>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">How should I store BYETTA?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Store your new, unused BYETTA Pen in the original carton in a refrigerator at 36Â°F to 46Â°F (2Â°C to 8Â°C).</item>
                                 <item>
                                    <caption>â¢</caption>After first use, keep your BYETTA Pen at a temperature cooler than 77Â°F (25Â°C).</item>
                                 <item>
                                    <caption>â¢</caption>Do not freeze your BYETTA Pen. Do not use BYETTA if it has been frozen.</item>
                                 <item>
                                    <caption>â¢</caption>Protect BYETTA from light.</item>
                                 <item>
                                    <caption>â¢</caption>Use a BYETTA Pen for only 30 days. Throw away a used BYETTA Pen after 30 days, even if there is some medicine left in the pen.</item>
                                 <item>
                                    <caption>â¢</caption>Do not use BYETTA after the expiration date printed on the label.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Keep your BYETTA Pen, pen needles, and all medicines out of the reach of children.</content>
                                 </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">General information about the safe and effective use of BYETTA.</content>
                              </paragraph>
                              <paragraph>Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use BYETTA for a condition for which it was not prescribed. Do not give BYETTA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your healthcare provider or pharmacist for information about BYETTA that is written for health professionals.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What are the ingredients in BYETTA?</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Active ingredient:</content> exenatide </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Inactive ingredients:</content> metacresol, mannitol, glacial acetic acid, and sodium acetate trihydrate in water for injection.</paragraph>
                              <paragraph>BYETTA<sup>Â®</sup> is a registered trademark of the AstraZeneca group of companies. All other trademarks are the trademarks of their respective owners.</paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>Distributed by:</paragraph>
                              <paragraph>AstraZeneca Pharmaceuticals LP</paragraph>
                              <paragraph>Wilmington, DE 19850</paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>For more information, call 1-800-236-9933.</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>This Medication Guide has been approved by the U.S. Food and Drug AdministrationÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Revised: 05/2025</paragraph>
               </text>
               <effectiveTime value="20250528"/>
            </section>
         </component>
         <component>
            <section ID="PUM1">
               <id root="2e3b206b-b3a2-4308-b54a-2c4d7f30da87"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <text>
                  <table styleCode="Noautorules" width="100%">
                     <col width="11%"/>
                     <col width="22%"/>
                     <col width="23%"/>
                     <col width="11%"/>
                     <col width="34%"/>
                     <tbody>
                        <tr>
                           <td align="center" colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">INSTRUCTIONS FOR USE<br/>BYETTA<sup>Â®</sup> (bye-A-tuh)</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">(exenatide) injection</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">for subcutaneous use</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">250 mcg/mL, 1.2 mL</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Do not share your BYETTA Pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Section 1</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Read this section completely before you begin. Then, move on to Section 2âGetting Started.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">WHAT YOU NEED TO KNOW ABOUT YOUR BYETTA PEN</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="5" valign="top">
                              <renderMultiMedia ID="id-1341305598" referencedObject="ID_8302eeda-e419-4998-b03a-c322ff0a1e22"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Read these instructions carefully BEFORE using your BYETTA Pen. </content>For complete dosing and safety information, also read the BYETTA Medication Guide that comes with the BYETTA Pen carton.</paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>It is important that you use your pen correctly. Failure to follow these instructions completely may result in a wrong dose, a broken pen or an infection.</paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>
                                 <content styleCode="bold">These instructions do not take the place of talking with your healthcare provider about your medical condition or your treatment. If you are having problems using your BYETTA Pen, call toll free 1-800-236-9933.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>Â </paragraph>
                              <paragraph>
                                 <content styleCode="bold">IMPORTANT INFORMATION ABOUT YOUR BYETTA PEN</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Each BYETTA Pen contains enough medicine for injection two times each day for 30 days. You do not have to measure any doses, the pen measures each dose for you.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Do not</content> mix BYETTA and insulin in the same syringe or vial even if you take them at the same time.</item>
                                 <item>
                                    <caption>â¢</caption>If any part of your pen appears broken or damaged, do not use the pen.</item>
                                 <item>
                                    <caption>â¢</caption>This BYETTA Pen is not recommended for use by people who are blind or have vision problems without the help of a person trained in the proper use of the pen.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Follow the injection method explained to you by your healthcare provider. </content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>Follow Section 2 only to set up a new pen before first use.</item>
                                 <item>
                                    <caption>â¢</caption>Section 3 of these Instructions for Use should be used for every injection.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">ABOUT PEN NEEDLES</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">What kinds of needles can be used with my BYETTA Pen? </content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Pen needles are not included with your pen.</content> You may need a prescription to get them from your pharmacist.</item>
                                 <item>
                                    <caption>â¢</caption>Use 29 (thin), 30, or 31 (thinner) gauge disposable pen needles with your BYETTA Pen. Ask your healthcare provider which needle gauge and length is best for you.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Do I use a new needle for each injection?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Yes. Do not reuse or share your needles with other people. You may give other people a serious infection or get a serious infection from them.</content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>Remove the needle from the pen immediately after you complete each injection. This will help prevent leakage of BYETTA, keep out air bubbles, reduce needle clogs, and decrease the risk of infection.</item>
                                 <item>
                                    <caption>â¢</caption>Do not push the injection button on your pen unless a needle is attached to the pen.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">How do I throw away my needles?</content>
                              </paragraph>
                              <paragraph>Put your used needles in a FDA-cleared sharps disposal container right away after use. Do not throw away (dispose of) loose needles and syringes in your household trash. If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:</paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Made of a heavy-duty plastic,</item>
                                 <item>
                                    <caption>â¢</caption>Can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,</item>
                                 <item>
                                    <caption>â¢</caption>Upright and stable during use, </item>
                                 <item>
                                    <caption>â¢</caption>Leak-resistant, and </item>
                                 <item>
                                    <caption>â¢</caption>Properly labeled to warn of hazardous waste inside the container.</item>
                              </list>
                              <paragraph>Â </paragraph>
                              <paragraph>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes.</paragraph>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Do not share your BYETTA Pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STORING YOUR BYETTA PEN</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">How do I store my BYETTA Pen?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Prior to first use, store your unused BYETTA Pen in the original carton in a refrigerator at 36Â°F to 46Â°F (2Â°C to 8Â°C).</item>
                                 <item>
                                    <caption>â¢</caption>After first use, your BYETTA Pen can be kept at a temperature cooler than 77Â°F (25Â°C).</item>
                                 <item>
                                    <caption>â¢</caption>Do not freeze your BYETTA Pen. Do not use BYETTA if it has been frozen. BYETTA should be protected from light.</item>
                                 <item>
                                    <caption>â¢</caption>When carrying the pen away from home, store the pen at a temperature between 36Â°F to 77Â°F (2Â°C to 25Â°C) and keep dry.</item>
                                 <item>
                                    <caption>â¢</caption>Do not store the pen with the needle attached. If the needle is left on the pen, BYETTA may leak from the pen and air bubbles may form in the cartridge.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Keep your pen and needles out of the reach of children.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">How long can I use a BYETTA Pen?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>You can use your BYETTA Pen for up to 30 days after setting up a new pen for first use. <content styleCode="bold">After 30 days, throw away the BYETTA Pen in a FDA-cleared sharps disposal container, even if it is not completely empty.</content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>Mark the date when you first used your pen and the date 30 days later in the spaces below:</item>
                              </list>
                              <paragraph>Â </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Date of First Use <content styleCode="underline">Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â </content>Â Date to Throw Away PenÂ <content styleCode="underline">Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  </content>
                                 </content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">BYETTA should not be used after the expiration date printed on the pen label.</content>
                                 </item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">How do I clean my BYETTA Pen?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Wipe the outside of the pen with a clean, damp cloth.</item>
                                 <item>
                                    <caption>â¢</caption>White particles may appear on the outside tip of the cartridge during normal use. You may remove them with an alcohol wipe or alcohol swab.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">See the complete BYETTA Medication Guide that comes with BYETTA. For more information, call toll free 1-800-236-9933. </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Section 2</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Read and follow the directions in this section only after you've read Section 1âWhat You Need To Know About Your BYETTA Pen.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top"/>
                        </tr>
                        <tr>
                           <td align="center" colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">GETTING STARTED</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>Set up your new pen just before you use it the first time. For routine use, do not repeat this one-time-only new pen setup. If you do, you will run out of BYETTA before 30 days of use.</paragraph>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="5" valign="top">
                              <renderMultiMedia ID="id2786" referencedObject="ID_7fead3d8-057a-42b0-8610-a07b88f5ec25"/>
                              <renderMultiMedia ID="id2787" referencedObject="ID_6acdcd44-7c4f-4d7e-b3ea-ac5836c754c4"/>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">ONE-TIME-ONLY NEW PEN SETUP</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP A Check the Pen</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id-443151953" referencedObject="C4F4A908-968D-41F1-9196-2425F5B66D26"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id-1687740963" referencedObject="B0EF325D-1F9A-4044-937F-0C8EF6AA5B0F"/>
                           </td>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Note:</content>  Small air bubbles in the cartridge are normal.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Wash hands prior to use.</item>
                                 <item>
                                    <caption>â¢</caption>Check pen label to make sure it is your 5 mcg pen.</item>
                                 <item>
                                    <caption>â¢</caption>Pull off the blue pen cap.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Check BYETTA in the cartridge. The liquid should be clear, colorless, and free of particles. If not, do not use.</item>
                              </list>
                           </td>
                           <td valign="top"/>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP B Attach the Needle</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id2821" referencedObject="dcd1c595-7b24-4813-aaf7-1506f0f6f63a"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id2824" referencedObject="a15bdfac-b7d3-42e9-a413-c3fddbcceae1"/>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id2827" referencedObject="ID_0ef8a5e9-3fea-4a92-ab14-fbbdbb17223c"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Remove paper tab from outer needle shield.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Push</content> outer needle shield containing the needle <content styleCode="bold">straight</content> onto the pen, then <content styleCode="bold">screw</content> needle on until secure.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off outer needle shield. <content styleCode="bold">Do not</content> throw away.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off inner needle shield and throw away. A small drop of liquid may appear. This is normal.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP C Dial the Dose</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id-131178911" referencedObject="ID_35f34ac0-83b7-4894-81a8-06b197f5cde3"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id-1561017725" referencedObject="ID_83d4e425-4c72-4932-9a7f-f2d1419ea8be"/>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id1301815329" referencedObject="ID_7c7aa240-17ce-47d3-b40d-b0629e473012"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Check that the <renderMultiMedia ID="id1980949388" referencedObject="ID_77f04500-e217-4b02-a6e5-8bdc05475cd6"/> is in the dose window. If not, turn dose knob away from you (clockwise) <content styleCode="bold">until it stops</content> and the <renderMultiMedia ID="id-717813790" referencedObject="ID_5a7cb025-bb27-4248-b99d-618e7bb4c6f0"/> is in the dose window. </item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Pull dose knob out until it stops</content> and the <renderMultiMedia ID="id-2068721179" referencedObject="FD35EE02-E24F-4693-AC96-DD2362F228B3"/> is in the dose window.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Turn dose knob away from you until it stops</content> at <renderMultiMedia ID="id1967384122" referencedObject="ID_44d23c68-c517-4c5f-baf6-56ba3b586128"/>. Make sure that the 5 with the line under it is in the center of the dose window.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you cannot turn the dose knob away from you to the <renderMultiMedia ID="id2883" referencedObject="ID_3cb32921-7b43-44ae-b224-70fa8ccd504b"/>, see <content styleCode="bold">Commonly Asked Questions, </content>number 7, in Section 4 of these Instructions for Use.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP D Prepare the Pen</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id2891" referencedObject="ID_55586e63-ee9c-447a-8029-768da5d854c4"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id2894" referencedObject="ID_30372dc0-11b5-4be1-9c90-69b6e3e9286a"/>
                              <paragraph>
                                 <content styleCode="bold">PUSH &amp; HOLD</content>
                              </paragraph>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id2897" referencedObject="ID_7e45f2a0-84bb-4803-b64b-6be47c8d4395"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Point the needle of the pen up and away from you.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Use thumb to firmly push injection button in until it stops,</content> then continue holding the injection button in while <content styleCode="bold">slowly counting to 5</content>. </item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">If you do not see a stream or several drops come from the needle tip, repeat Steps C &amp; D.</content>
                                 </item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pen preparation is complete when the <renderMultiMedia ID="id-643508353" referencedObject="ID_58da8b0d-8f48-47fb-ad9c-c81541457046"/> is in the center of the dose window <content styleCode="bold">and</content> you have seen a stream or several drops come from the needle tip.  </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you do not see liquid after 4 times, see <content styleCode="bold">Commonly Asked Questions, </content>number 3, in Section 4 of these Instructions for Use.</paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP E Complete New Pen Setup</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id2929" referencedObject="ID_1982d1a4-5808-4abb-b242-cce0ffd98634"/>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Turn dose knob away from you until it stops</content> and the <renderMultiMedia ID="id-2107387098" referencedObject="eff4b3e9-8aba-4206-8b98-4501ff95d65a"/> is in the dose window.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">For routine use,</content> do not repeat this one-time-only new pen setup. If you do, you will run out of BYETTA before 30 days of use.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>You are now ready for your first dose of BYETTA.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Go to Section 3, Step 3, for instructions on how to inject your first routine dose.</content>
                                 </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you cannot turn the dose knob, see <content styleCode="bold">Commonly Asked Questions, </content>number 7, in Section 4 of Instructions for Use.<br/>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Section 3</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Now that you have done the one-time-only new pen setup, follow Section 3 for all of your injections.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">ROUTINE USE</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">STEP 1 Check the Pen</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id2964" referencedObject="e46891f5-84ec-4699-a8fd-e6b7e4e787c5"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id2967" referencedObject="ID_3bf15e7d-0217-4d65-8842-e31876f2fed5"/>
                           </td>
                           <td rowspan="2" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Note:</content>  Small air bubbles will not harm you or affect your dose.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Wash hands prior to use.</item>
                                 <item>
                                    <caption>â¢</caption>Check pen label to make sure it is your 5 mcg pen.</item>
                                 <item>
                                    <caption>â¢</caption>Pull off the blue pen cap.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Check BYETTA in the cartridge.</item>
                                 <item>
                                    <caption>â¢</caption>The liquid should be clear, colorless, and free of particles. If it is not, do not use.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 2 Attach the Needle</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id-1980991644" referencedObject="ID_85724ba8-4640-4fc7-be4b-9fb9906010f8"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id1887367489" referencedObject="D53B019E-59A0-4470-B3B4-103B9B0BB1F6"/>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id-740106510" referencedObject="B10A7927-63E7-45B7-AE85-959666708A26"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Remove paper tab from outer needle shield.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Push</content> outer needle shield containing the needle <content styleCode="bold">straight</content> onto pen, then <content styleCode="bold">screw</content> needle on until secure.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off outer needle shield. <content styleCode="bold">Do not</content> throw away.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off inner needle shield and throw away. A small drop of liquid may appear. This is normal.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 3 Dial the Dose</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id3022" referencedObject="ID_38a62998-408f-4e18-8726-b8f6add879f2"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id3025" referencedObject="ID_1eaf2355-1ffc-47a2-9635-818af1473caf"/>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id-786198239" referencedObject="A28C3F1C-2669-4242-B98F-1C1D406D7753"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Check that the <renderMultiMedia ID="id-2107386929" referencedObject="ID_009f4d03-31b0-4191-91dd-578dd01ee139"/> is in the dose window. If not, turn dose knob away from you (clockwise) <content styleCode="bold">until it stops</content> and the <renderMultiMedia ID="id-2107386760" referencedObject="ID_6021f281-7abb-466d-a75d-639956b43d9e"/> is in the dose window.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Pull dose knob out until it stops</content> and the <renderMultiMedia ID="id-2085911845" referencedObject="ID_977d0698-2deb-457f-ae4a-24cfab0b94c5"/> is in the dose window.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Turn dose knob away from you until it stops</content> at <renderMultiMedia ID="id-2085912465" referencedObject="e4ac0b7b-414c-499b-9273-fe0bab18400c"/>. Make sure that the 5 with the line under it is in the center of the dose window.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you cannot turn the dose knob away from you to the <renderMultiMedia ID="id-2085912296" referencedObject="ID_49684348-f143-4763-b640-979e2d85d254"/>, see<content styleCode="bold"> Commonly Asked Questions, </content>number 7, in Section 4 of these Instructions for Use.</paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 4 Inject the Dose</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id3060" referencedObject="ID_7200b04d-5a45-47ac-8832-78b0298a423b"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id3063" referencedObject="aebd277a-1017-489d-85be-4c576f38ffc8"/>
                              <paragraph>
                                 <content styleCode="bold">PUSH &amp; HOLD</content>
                              </paragraph>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id3066" referencedObject="e5d35c4b-b3d7-4015-9503-a74ae0893369"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Grip pen firmly.</item>
                                 <item>
                                    <caption>â¢</caption>Insert needle into skin using the under-the-skin (subcutaneous) injection method explained by your healthcare provider.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Use thumb to firmly push injection button in until it stops. </content>Continue holding in the injection button while <content styleCode="bold">slowly counting to 5</content> to get a full dose.</item>
                                 <item>
                                    <caption>â¢</caption>Remove needle from skin.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Injection is complete when the <renderMultiMedia ID="id-2085912127" referencedObject="ID_14b43661-d238-47d8-b26f-d05e4dfa7d41"/> is in the center of the dose window.</item>
                                 <item>
                                    <caption>â¢</caption>The pen is now ready to reset.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you see several drops of BYETTA leaking from the needle after the injection, you may not have received a complete dose. See <content styleCode="bold">Commonly Asked Questions, </content>number 4, in Section 4 of these Instructions for Use.</paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 5 Reset the Pen</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id-2085911958" referencedObject="bb06b8a5-8e76-4a1e-86ec-22d4b1a565f2"/>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Turn dose knob away from you until it stops</content> and the <renderMultiMedia ID="id-2085911676" referencedObject="c87f1654-2160-42c7-8193-0920d38680d1"/> is in the dose window.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you cannot turn the dose knob, or if your pen leaks, your full dose has not been delivered. See <content styleCode="bold">Commonly Asked Questions, </content>numbers 4 and 7, in Section 4 of these Instructions for Use.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 6 Remove and Dispose of the Needle</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id3120" referencedObject="ID_94852a21-2345-401c-85f9-c66cf4c8bd93"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id3123" referencedObject="afd41642-03c2-4d77-b3bb-febea794a348"/>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id3126" referencedObject="ID_967f9b1f-e73e-40af-9398-38d811d40852"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Carefully put the outer needle shield back over the needle.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Remove the needle after each injection.</content>
                                 </item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Unscrew the needle.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Throw away needles in a FDA-cleared sharps disposal container (See above <content styleCode="bold">âHow do I throw away my needles?â</content>) or as recommended by your healthcare provider.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 7 Store Pen for Next Dose</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Replace Blue Pen Cap on pen before storage.</item>
                                 <item>
                                    <caption>â¢</caption>Store your BYETTA Pen at a temperature between 36Â°F to 77Â°F (2Â°C to 25Â°C). (See<content styleCode="bold"> Storing Your BYETTA Pen</content> in Section 1 of these Instructions for Use for complete storage information.)</item>
                                 <item>
                                    <caption>â¢</caption>When it is time for your next routine dose, go to <content styleCode="bold">Section 3, Step 1,</content> and repeat Steps 1â7.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Section 4</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">COMMONLY ASKED QUESTIONS</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">1.</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Do I need to do the One-Time-Only New Pen Setup before every dose?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>No. <content styleCode="bold">The One-Time-Only New Pen Setup is done only once, just before each new pen is used for the first time.</content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>The purpose of the setup is to make sure that your BYETTA Pen is ready to use for the next 30 days.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">If you repeat the One-Time-Only New Pen Setup before each routine dose, you will not have enough BYETTA for 30 days.</content> The small amount of BYETTA used in the new pen setup will not affect the 30-day supply of BYETTA.</item>
                              </list>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">2. </content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Why are there air bubbles in the cartridge?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>A small air bubble is normal. It will not harm you or affect your dose.</item>
                                 <item>
                                    <caption>â¢</caption>If the pen is stored with a needle attached, air bubbles may form in the cartridge. <content styleCode="bold">Do not</content> store the pen with the needle attached.</item>
                              </list>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">3.</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">What should I do if BYETTA does not come out of the needle tip after four tries during One-Time-Only New Pen Setup?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Carefully put the outer needle shield back over the needle. Remove the needle by unscrewing it. Throw away the needle properly.</item>
                                 <item>
                                    <caption>â¢</caption>Attach a new needle and repeat <content styleCode="bold">One-Time-Only New Pen Setup, Steps BâE,</content> in Section 2 of these Instructions for Use. Once you see several drops or a stream of liquid coming out of the tip of the needle, the setup is complete.</item>
                              </list>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td rowspan="2" valign="top">
                              <paragraph>
                                 <content styleCode="bold">4.</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Why do I see BYETTA leaking from my needle after I have finished my injection?</content>
                              </paragraph>
                              <paragraph>Â <br/>It is normal for a single drop to remain on the tip of your needle after your injection is complete. If you see more than one drop:</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>You may not have received your full dose. <content styleCode="bold">Do not inject another dose.</content> Talk with your healthcare provider about what to do about a partial dose.</item>
                                 <item>
                                    <caption>â¢</caption>To make sure that you get your full dose, when you take your injections, <content styleCode="bold">firmly push and hold</content> the injection button in and <content styleCode="bold">slowly count to 5</content> (see <content styleCode="bold">Section 3, Step 4: Inject the Dose</content>).</item>
                              </list>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">5.</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">How can I tell when the injection is complete?</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <paragraph>Â </paragraph>
                              <paragraph>The injection is complete when:</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>You have firmly pushed the injection button in all the way <content styleCode="bold">until it stops</content>
                                 </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td align="center" colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">and</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">You have slowly counted to 5</content> while you are still holding the injection button in and the needle is still in your skin</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td align="center" colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">and</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>The <renderMultiMedia ID="id-2085911449" referencedObject="dbb6e68d-7033-444a-811a-2efeda4f63c2"/> is in the center of the dose window.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <paragraph>Â </paragraph>
                              <paragraph>If you hear a click sound from your BYETTA Pen, ignore it. You must follow all the steps listed above to make sure your injection is complete.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">6.</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Where should I inject BYETTA?</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="2" valign="top">
                              <paragraph>Inject BYETTA into your abdomen, thigh, or upper arm using the injection method explained to you by your healthcare provider.</paragraph>
                              <paragraph>Change (rotate) your injection sites within the area you choose for each dose.Â <content styleCode="bold">Do not</content>Â use the same injection site for each injection.</paragraph>
                              <paragraph>Â </paragraph>
                           </td>
                           <td colspan="2" valign="top">
                              <renderMultiMedia ID="id3206" referencedObject="ID_951c38c3-e6e7-4bca-b40b-f8af2118279b"/>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">7.</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">What if I cannot pull, turn, or push the dose knob?</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <paragraph>Check the symbol in the dose window. Follow the steps next to the matching symbol.</paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>
                                 <content styleCode="bold">If </content>
                                 <renderMultiMedia ID="id956455097" referencedObject="ID_907b0f08-18fe-4328-bf4d-48161df06a31"/>
                                 <content styleCode="bold"> is in  the dose window:</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull the dose knob out until <renderMultiMedia ID="id-2085911280" referencedObject="e0e70eea-cea2-42d3-be4b-0f8b1a174264"/> appears.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">If </content>
                                 <renderMultiMedia ID="id-2085911111" referencedObject="ID_893631aa-c02d-4160-9656-590e9c489635"/>
                                 <content styleCode="bold"> is in the dose window and the dose knob will not turn:</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>The cartridge in your BYETTA Pen may not have enough medicine to deliver a full dose. A small amount of BYETTA will always stay in the cartridge. If the cartridge contains a small amount and the dose knob will not turn, your pen does not have enough BYETTA and will not deliver any more doses. Get a new BYETTA Pen.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">If </content>
                                 <renderMultiMedia ID="id2136773212" referencedObject="ID_65ec8e75-6dbd-46e1-bbd4-25ab416cc141"/>
                                 <content styleCode="bold"> and part of </content>
                                 <renderMultiMedia ID="id-2085910942" referencedObject="ID_88ff362b-7b1b-4431-ba6a-454bd7179e48"/>
                                 <content styleCode="bold"> are in the dose window and the dose knob cannot be pushed in:</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>The dose knob was not turned all the way. Continue turning the dose knob away from you until <renderMultiMedia ID="id-2085910773" referencedObject="c0f9081b-2592-43d7-b2b6-7619c53eab17"/> is in the center of the dose window.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">If part of </content>
                                 <renderMultiMedia ID="id-2085910604" referencedObject="ID_27d933b7-92bd-4c05-9bbd-ab2d3256af3e"/>
                                 <content styleCode="bold">and part of </content>
                                 <renderMultiMedia ID="id-2085910435" referencedObject="ID_4258ab34-26f9-497a-9de7-a694ad846b13"/>
                                 <content styleCode="bold"> are in the dose window and the dose knob cannot be pushed in: </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="4" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>The needle may be clogged, bent, or incorrectly attached.</item>
                                 <item>
                                    <caption>â¢</caption>Attach a new needle. Make sure needle is on straight and screwed on all the way.</item>
                                 <item>
                                    <caption>â¢</caption>Firmly push the injection button in all the way. BYETTA should come from needle tip.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">If </content>
                                 <renderMultiMedia ID="id-2085910266" referencedObject="ID_55cdd60d-f703-46de-a659-0459d3599b47"/>
                                 <content styleCode="bold"> is in the dose window and the dose knob will not turn: </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>The injection button was not pushed in all the way and a complete dose was not delivered. <content styleCode="bold">Talk with your healthcare provider about what to do about a partial dose. </content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>Follow these steps to reset your pen for your next injection:<list listType="unordered">
                                       <item>
                                          <caption>â</caption>Firmly push the injection button in all the way <content styleCode="bold">until it stops</content>. Keep holding the injection button in and <content styleCode="bold">slowly count to 5</content>. Then release the injection button and turn the dose knob away from you until   appears in the dose window.</item>
                                       <item>
                                          <caption>â</caption>If you cannot turn the dose knob, the needle may be clogged. Replace the needle and repeat the step above.</item>
                                    </list>
                                 </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>Â </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>For your next dose, be sure to <content styleCode="bold">firmly push and hold</content> the injection button in and <content styleCode="bold">slowly count to 5</content> before removing needle from skin.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">See the complete BYETTA Medication Guide that comes with BYETTA. For more information, call toll free 1-800-236-9933.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>Distributed by:<br/>AstraZeneca Pharmaceuticals LP<br/>Wilmington, DE 19850 </paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>BYETTA<sup>Â®</sup> is a registered trademark of the AstraZeneca group of companies.</paragraph>
                              <paragraph>This Instructions for Use has been approved by the U.S. Food and Drug Administration.</paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>Revised: May 2025</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20250528"/>
               <component>
                  <observationMedia ID="ID_8302eeda-e419-4998-b03a-c322ff0a1e22">
                     <text>Byetta Pen 5mcg</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-02.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_7fead3d8-057a-42b0-8610-a07b88f5ec25">
                     <text>Byetta parts</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-05.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_6acdcd44-7c4f-4d7e-b3ea-ac5836c754c4">
                     <text>penneedleparts</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-06.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="C4F4A908-968D-41F1-9196-2425F5B66D26">
                     <text>Check the pen</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-03.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="B0EF325D-1F9A-4044-937F-0C8EF6AA5B0F">
                     <text>Check Betta cartidge</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-04.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="dcd1c595-7b24-4813-aaf7-1506f0f6f63a">
                     <text>Remove paper from needle</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-09.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="a15bdfac-b7d3-42e9-a413-c3fddbcceae1">
                     <text>Pull off outer needle</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-10.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_0ef8a5e9-3fea-4a92-ab14-fbbdbb17223c">
                     <text>Pull off inner needle shield</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-11.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_35f34ac0-83b7-4894-81a8-06b197f5cde3">
                     <text>Check the dose window</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-05.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_83d4e425-4c72-4932-9a7f-f2d1419ea8be">
                     <text>Pull dose knob out</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-06.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_7c7aa240-17ce-47d3-b40d-b0629e473012">
                     <text>Turn dose knob</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-07.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_77f04500-e217-4b02-a6e5-8bdc05475cd6">
                     <text>right facing arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-51.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_5a7cb025-bb27-4248-b99d-618e7bb4c6f0">
                     <text>right facing arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-52.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="FD35EE02-E24F-4693-AC96-DD2362F228B3">
                     <text>Up facing arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-41.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_44d23c68-c517-4c5f-baf6-56ba3b586128">
                     <text>number five</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-56.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_3cb32921-7b43-44ae-b224-70fa8ccd504b">
                     <text>5</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-17.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_55586e63-ee9c-447a-8029-768da5d854c4">
                     <text>Point needle away from you</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-18.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_30372dc0-11b5-4be1-9c90-69b6e3e9286a">
                     <text>Push and Hold</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-19.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_7e45f2a0-84bb-4803-b64b-6be47c8d4395">
                     <text>Pen preparation</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-20.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_58da8b0d-8f48-47fb-ad9c-c81541457046">
                     <text>triangle1</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-53.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_1982d1a4-5808-4abb-b242-cce0ffd98634">
                     <text>Turn dose window</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-33.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="eff4b3e9-8aba-4206-8b98-4501ff95d65a">
                     <text>arrow pointing right</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Step-E-arrow-5mcg.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="e46891f5-84ec-4699-a8fd-e6b7e4e787c5">
                     <text>Check pen label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-22.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_3bf15e7d-0217-4d65-8842-e31876f2fed5">
                     <text>Check cartridge</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-23.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_85724ba8-4640-4fc7-be4b-9fb9906010f8">
                     <text>Remove paper tab</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-08.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="D53B019E-59A0-4470-B3B4-103B9B0BB1F6">
                     <text>Pull off needle shield</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-09.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="B10A7927-63E7-45B7-AE85-959666708A26">
                     <text>Pull off inner needle shield and throw away</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-10.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_38a62998-408f-4e18-8726-b8f6add879f2">
                     <text>Check window dose</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-27.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_1eaf2355-1ffc-47a2-9635-818af1473caf">
                     <text>Pull dose knob</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-28.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="A28C3F1C-2669-4242-B98F-1C1D406D7753">
                     <text>Turn knob away</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-11.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_009f4d03-31b0-4191-91dd-578dd01ee139">
                     <text>arrow pointing right</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Step-3-arrow-5mcg.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_6021f281-7abb-466d-a75d-639956b43d9e">
                     <text>arrow pointing right</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Step-3-arrow-dose-5mcg.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_977d0698-2deb-457f-ae4a-24cfab0b94c5">
                     <text>arrow pointing up</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Pull-dos-5mcg.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="e4ac0b7b-414c-499b-9273-fe0bab18400c">
                     <text>5</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Turn-dos-5mcg.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_49684348-f143-4763-b640-979e2d85d254">
                     <text>5</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Note-5mcg.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_7200b04d-5a45-47ac-8832-78b0298a423b">
                     <text>Grip pen firmly</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-30.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="aebd277a-1017-489d-85be-4c576f38ffc8">
                     <text>Push and hold</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-31.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="e5d35c4b-b3d7-4015-9503-a74ae0893369">
                     <text>Injection is complete</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-32.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_14b43661-d238-47d8-b26f-d05e4dfa7d41">
                     <text>arrow pointing up</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Injection-arrow.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="bb06b8a5-8e76-4a1e-86ec-22d4b1a565f2">
                     <text>Turn dose 5mcg</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Turn-dose-5mcg-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="c87f1654-2160-42c7-8193-0920d38680d1">
                     <text>arrow pointing right</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Reset-5mcg-arrow.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_94852a21-2345-401c-85f9-c66cf4c8bd93">
                     <text>Carefully put the outer needle</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-34.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="afd41642-03c2-4d77-b3bb-febea794a348">
                     <text>Unscrew the needle</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-35.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_967f9b1f-e73e-40af-9398-38d811d40852">
                     <text>Throw away needles</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-36.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="dbb6e68d-7033-444a-811a-2efeda4f63c2">
                     <text>triangle2</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Injection-complete-arrow.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_951c38c3-e6e7-4bca-b40b-f8af2118279b">
                     <text>Where to inject Byetta</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-37.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_907b0f08-18fe-4328-bf4d-48161df06a31">
                     <text>rightarrow1</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-54.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="e0e70eea-cea2-42d3-be4b-0f8b1a174264">
                     <text>plus sign</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Pull-out-arrow.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_893631aa-c02d-4160-9656-590e9c489635">
                     <text>Up facing arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Arrow-for-dose-knob.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_65ec8e75-6dbd-46e1-bbd4-25ab416cc141">
                     <text>up facing arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="pushed-in-arrow.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_88ff362b-7b1b-4431-ba6a-454bd7179e48">
                     <text>5</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="5mcg-window.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="c0f9081b-2592-43d7-b2b6-7619c53eab17">
                     <text>5</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Turn-knob-away-arrow.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_27d933b7-92bd-4c05-9bbd-ab2d3256af3e">
                     <text>5</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="5mcg-cannot-be-pushed-in.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_4258ab34-26f9-497a-9de7-a694ad846b13">
                     <text>arrow pointing up</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Arrow-in-dose-window-cannot-be-pushed-in.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_55cdd60d-f703-46de-a659-0459d3599b47">
                     <text>Arrow pointing up</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Arrow-knob-won't-turn.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_a97e4236-aba0-4fd8-8aa1-381b528d6f90">
               <id root="8014d5f9-71fb-4b1a-b7f1-b528e126739e"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>Medication Guide </title>
               <text>
                  <table styleCode="Noautorules" width="100%">
                     <col width="5%"/>
                     <col width="9%"/>
                     <col width="21%"/>
                     <col width="22%"/>
                     <col width="10%"/>
                     <col width="32%"/>
                     <tbody>
                        <tr>
                           <td align="center" colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                                 <br/>
                                 <content styleCode="bold">BYETTA<sup>Â®</sup> (bye-A-tuh)</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">(exenatide) injection</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">for subcutaneous use</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">250 mcg/mL, 2.4 mL</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Do not share your BYETTA Pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Section 1</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Read this section completely before you begin. Then, move on to Section 2âGetting Started.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">WHAT YOU NEED TO KNOW ABOUT YOUR BYETTA PEN</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="6" valign="top">
                              <renderMultiMedia ID="id938491492" referencedObject="ID_6356dd5a-bda1-470f-8241-194494c91ec8"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">PEN INSTRUCTIONS FOR USE</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Read these instructions carefully BEFORE using your BYETTA Pen</content>. For complete dosing and safety information, also read the BYETTA Medication Guide that comes with the BYETTA Pen carton.</paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>It is important that you use your pen correctly. Failure to follow these instructions completely may result in a wrong dose, a broken pen or an infection.</paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">These instructions do not take the place of talking with your healthcare provider about your medical condition or your treatment. If you are having problems using your BYETTA Pen, call toll free 1-800-236-9933. </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">IMPORTANT INFORMATION ABOUT YOUR BYETTA PEN </content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Each BYETTA Pen contains enough medicine for injection two times each day for 30 days. You do not have to measure any doses, the pen measures each dose for you.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Do not</content> mix BYETTA and insulin in the same syringe or vial even if you take them at the same time.</item>
                                 <item>
                                    <caption>â¢</caption>If any part of your pen appears broken or damaged, do not use the pen.</item>
                                 <item>
                                    <caption>â¢</caption>This BYETTA Pen is not recommended for use by people who are blind or have vision problems without the help of a person trained in the proper use of the pen.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Follow the injection method explained to you by your healthcare provider. </content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>Follow Section 2 only to set up a new pen before first use.</item>
                                 <item>
                                    <caption>â¢</caption>Section 3 of these Instructions for Use should be used for every injection.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">ABOUT PEN NEEDLES </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">What kinds of needles can be used with my BYETTA Pen? </content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Pen needles are not included with your pen.</content> You may need a prescription to get them from your pharmacist.</item>
                                 <item>
                                    <caption>â¢</caption>Use 29 (thin), 30, or 31 (thinner) gauge disposable pen needles with your BYETTA Pen. Ask your healthcare provider which needle gauge and length is best for you.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Do I use a new needle for each injection?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Yes. Do not reuse or share your needles with other people. You may give other people a serious infection or get a serious infection from them.</content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>Remove the needle from the pen immediately after you complete each injection. This will help prevent leakage of BYETTA, keep out air bubbles, reduce needle clogs, and decrease the risk of infection.</item>
                                 <item>
                                    <caption>â¢</caption>Do not push the injection button on your pen unless a needle is attached to the pen.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">How do I throw away my needles?</content>
                              </paragraph>
                              <paragraph>Put your used needles in a FDA-cleared sharps disposal container right away after use. Do not throw away (dispose of) loose needles and syringes in your household trash. If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:</paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Made of a heavy-duty plastic, </item>
                                 <item>
                                    <caption>â¢</caption>Can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,</item>
                                 <item>
                                    <caption>â¢</caption>Upright and stable during use, </item>
                                 <item>
                                    <caption>â¢</caption>Leak-resistant, and</item>
                                 <item>
                                    <caption>â¢</caption>Properly labeled to warn of hazardous waste inside the container.</item>
                              </list>
                              <paragraph>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Do not share your BYETTA Pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">STORING YOUR BYETTA PEN </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">How do I store my BYETTA Pen?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Prior to first use, store your unused BYETTA Pen in the original carton in a refrigerator at 36Â°F to 46Â°F (2Â°C to 8Â°C).</item>
                                 <item>
                                    <caption>â¢</caption>After first use, your BYETTA Pen can be kept at a temperature cooler than 77Â°F (25Â°C).</item>
                                 <item>
                                    <caption>â¢</caption>Do not freeze your BYETTA Pen. Do not use BYETTA if it has been frozen. BYETTA should be protected from light.</item>
                                 <item>
                                    <caption>â¢</caption>When carrying the pen away from home, store the pen at a temperature between 36Â°F to 77Â°F (2Â°C to 25Â°C) and keep dry.</item>
                                 <item>
                                    <caption>â¢</caption>Do not store the pen with the needle attached. If the needle is left on the pen, BYETTA may leak from the pen and air bubbles may form in the cartridge.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Keep your pen and needles out of the reach of children.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">How long can I use a BYETTA Pen?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>You can use your BYETTA Pen for up to 30 days after setting up a new pen for first use. <content styleCode="bold">After 30 days, throw away the BYETTA Pen in a FDA-cleared sharps disposal container, even if it is not completely empty. </content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>Mark the date when you first used your pen and the date 30 days later in the spaces below:</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Date of First Use <content styleCode="underline">Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â </content>Â Date to Throw Away PenÂ <content styleCode="underline">Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  </content>
                                 </content>
                              </paragraph>
                              <paragraph>Â </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">BYETTA should not be used after the expiration date printed on the pen label.</content>
                                 </item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">How do I clean my BYETTA Pen?</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Wipe the outside of the pen with a clean, damp cloth.</item>
                                 <item>
                                    <caption>â¢</caption>White particles may appear on the outside tip of the cartridge during normal use. You may remove them with an alcohol wipe or alcohol swab.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">See the complete BYETTA Medication Guide that comes with BYETTA. For more information, call toll free 1-800-236-9933.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Section 2</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Read and follow the directions in this section only after you've read Section 1âWhat You Need To Know About Your BYETTA Pen</content>.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">GETTING STARTED</content>
                              </paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>Set up your new pen just before you use it the first time. For routine use, do not repeat this one-time-only new pen setup. If you do, you will run out of BYETTA before 30 days of use.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <renderMultiMedia ID="id-853337986" referencedObject="ID_356b96cf-7b0d-40ae-b3be-b3d576899e8b"/>
                              <renderMultiMedia ID="id-450621420" referencedObject="ID_03400a55-02cc-4d84-89d6-d0a6d3fa8273"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">ONE-TIME-ONLY NEW PEN SETUP</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP A Check the Pen</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="3" valign="top">
                              <renderMultiMedia ID="id156035628" referencedObject="D7AEE561-A2E2-431D-8423-3FE6162F076B"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id392321911" referencedObject="ID_77619733-a559-40b4-aa61-7cee9346cf3a"/>
                           </td>
                           <td rowspan="2" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Note:</content>  Small air bubbles in the cartridge are normal.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Wash hands prior to use.</item>
                                 <item>
                                    <caption>â¢</caption>Check pen label to make sure it is your 10 mcg pen.</item>
                                 <item>
                                    <caption>â¢</caption>Pull off the blue pen cap.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Check BYETTA in the cartridge. The liquid should be clear, colorless, and free of particles. If not, do not use.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP B Attach the Needle</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="3" valign="top">
                              <renderMultiMedia ID="id1185558178" referencedObject="ID_38e79ef6-6911-4555-884e-cb7538c09d84"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id1112471520" referencedObject="A4802CAF-DAEE-4005-BA50-DA8532E344CE"/>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id-973594653" referencedObject="ID_04137db8-04ac-474e-aa5f-fbd404e2aa71"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Remove paper tab from outer needle shield.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Push</content> outer needle shield containing the needle <content styleCode="bold">straight</content> onto the pen, then <content styleCode="bold">screw</content> needle on until secure.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off outer needle shield. <content styleCode="bold">Do not</content> throw away.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off inner needle shield and throw away. A small drop of liquid may appear. This is normal.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP C Dial the Dose</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="3" valign="top">
                              <renderMultiMedia ID="id-1783482797" referencedObject="ID_83a42af8-d599-41ba-94a7-7f2c366e6b7c"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id1613625199" referencedObject="ID_75cc9339-66ce-4903-aeee-26d055f8ec88"/>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id-1186284587" referencedObject="ID_71462db2-3c12-4858-9325-098caba2867c"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Check that the <renderMultiMedia ID="id792409777" referencedObject="ID_53381eed-f380-4173-a42c-a3571f5ada02"/> is in the dose window. If not, turn dose knob away from you (clockwise) <content styleCode="bold">until it stops</content> and the <renderMultiMedia ID="id1802268438" referencedObject="E268FABA-BCD3-4911-99A9-8898888C0347"/> is in the dose window.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Pull dose knob out until it stops</content> and the <renderMultiMedia ID="id-146666849" referencedObject="ID_53dae1d8-388c-46b9-a4bb-cfdc280aecf3"/> is in the dose window.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Turn dose knob away from you until it stops</content> at <renderMultiMedia ID="id-1082289444" referencedObject="AAF3F374-B4E7-421E-98DF-2EAC75005445"/>. Make sure that the 10 with the line under it is in the center of the dose window.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>Â </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you cannot turn the dose knob away from you to the <renderMultiMedia ID="id1918204264" referencedObject="ID_335a7a54-6637-436a-a7b4-e3d30bbbbc50"/>, see<content styleCode="bold"> Commonly Asked Questions, </content>number 7, in Section 4 of these Instructions for Use.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>Â </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP D Prepare the Pen</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="3" valign="top">
                              <renderMultiMedia ID="id-405989088" referencedObject="ID_9c698999-16c7-48f6-b1d5-513779faeab4"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <paragraph>
                                 <renderMultiMedia ID="id880204053" referencedObject="ID_56ffa3d3-5038-4dfe-891f-6cfbcaed3828"/>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">PUSH &amp; HOLD</content>
                              </paragraph>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id1605533186" referencedObject="AAF4B944-8DB6-4022-9493-BE8CD3825E0B"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Point the needle of the pen up and away from you.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Use thumb to firmly push injection button in until it stops, then continue holding the injection button in <content styleCode="bold">while slowly counting to 5. </content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">If you do not see a stream or several drops come from the needle tip, repeat Steps C &amp; D.</content>
                                 </item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pen preparation is complete when the <renderMultiMedia ID="id1861537609" referencedObject="ID_6536d366-c206-48a9-9f35-b67bf78bb48a"/> is in the center of the dose window <content styleCode="bold">and</content> you have seen a stream or several drops come from the needle tip.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you do not see liquid after 4 times, see <content styleCode="bold">Commonly Asked Questions, </content>number 3, in Section 4 of these Instructions for Use.</paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP E Complete New Pen Setup</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="3" valign="top">
                              <renderMultiMedia ID="id-1872984154" referencedObject="ID_5344c52d-37d5-44ed-b2e0-0508e68674cf"/>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Turn dose knob away from you until it stops</content> and the <renderMultiMedia ID="id932627365" referencedObject="ID_5d611962-5536-4d14-8933-583858338b3c"/> is in the dose window.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">For routine use,</content> do not repeat this one-time-only new pen setup. If you do, you will run out of BYETTA before 30 days of use.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>You are now ready for your first dose of BYETTA.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Go to Section 3, Step 3, for instructions on how to inject your first routine dose.</content>
                                 </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you cannot turn the dose knob, see <content styleCode="bold">Commonly Asked Questions, </content>number 7, in Section 4 of these Instructions for Use.Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Section 3</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Now that you have done the one-time-only new pen setup, follow Section 3 for all of your injections.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">ROUTINE USE</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">STEP 1 Check the Pen</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="3" valign="top">
                              <renderMultiMedia ID="id133455680" referencedObject="ID_2cde2c36-d84d-4cde-ad45-f0eea9b958d4"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id1994127590" referencedObject="ID_062d12ee-dc62-4206-85d1-b7d1128ee1d4"/>
                           </td>
                           <td rowspan="2" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Note:</content>  Small air bubbles will not harm you or affect your dose.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Wash hands prior to use.</item>
                                 <item>
                                    <caption>â¢</caption>Check pen label to make sure it is your 10 mcg pen.</item>
                                 <item>
                                    <caption>â¢</caption>Pull off the blue pen cap.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Check BYETTA in the cartridge.</item>
                                 <item>
                                    <caption>â¢</caption>The liquid should be clear, colorless, and free of particles. If it is not, do not use.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 2 Attach the Needle</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="3" valign="top">
                              <renderMultiMedia ID="id-351811413" referencedObject="ID_112a4d08-27d1-4780-a7ef-e66099d66f18"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id-1454009062" referencedObject="ID_901ec7bf-8cfc-4a0a-b479-a9e5044a2206"/>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id1911271721" referencedObject="ID_7b8daf75-04ad-478e-a7af-734880d0fc0c"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Remove paper tab from outer needle shield.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Push</content> outer needle shield containing the needle <content styleCode="bold">straight</content> onto pen, then <content styleCode="bold">screw</content> needle on until secure.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off outer needle shield. <content styleCode="bold">Do not</content> throw away.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull off inner needle shield and throw away. A small drop of liquid may appear. This is normal.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 3 Dial the Dose</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="3" valign="top">
                              <renderMultiMedia ID="id-838543208" referencedObject="ID_9a473891-4c8d-4c6f-b02d-7d4b8c72d5d0"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id-1157377750" referencedObject="ID_5fd59447-318e-477b-9946-df7867d5853b"/>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id-1361964595" referencedObject="D946F68F-5DA2-46F0-B215-0A122751335F"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Check that the <renderMultiMedia ID="id821703342" referencedObject="A9748551-52BC-4476-BFE0-54F0078162B9"/> is in the dose window. If not, turn dose knob away from you (clockwise) <content styleCode="bold">until it stops</content> and the <renderMultiMedia ID="id-1865751882" referencedObject="ID_084d3851-7959-4252-8f78-bb37715f479f"/> is in the dose window.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Pull dose knob out until it stops</content> and the <renderMultiMedia ID="id-764376104" referencedObject="BE4AD158-35F0-4FBA-AFA7-16E3C7D5F22C"/> is in the dose window.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Turn dose knob away from you until it stops</content> at <renderMultiMedia ID="id1304050608" referencedObject="A4C61307-7ACE-4CFD-BCCB-7CFDF96C3AD8"/>. Make sure that the 10 with the line under it is in the center of the dose window.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you cannot turn the dose knob away from you to the <renderMultiMedia ID="id620045410" referencedObject="ID_9ec894ac-9ab1-4de1-97e3-77cc08320af1"/>, see<content styleCode="bold"> Commonly Asked Questions, </content>number 7, in Section 4 of these Instructions for Use.</paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 4 Inject the Dose</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="3" valign="top">
                              <renderMultiMedia ID="id75169038" referencedObject="CA8E0064-4A49-4823-B749-DA1EA49E8B63"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id2038149608" referencedObject="ID_2d3b5be3-80c1-46f5-987e-85f9ee4eece1"/>
                              <paragraph>
                                 <content styleCode="bold">PUSH &amp; HOLD</content>
                              </paragraph>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id1879130441" referencedObject="ID_61de1d24-ed49-49bc-a03c-531245134c65"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Grip pen firmly.</item>
                                 <item>
                                    <caption>â¢</caption>Insert needle into skin using the under-the-skin (subcutaneous) injection method explained by your healthcare provider.</item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Use thumb to firmly push injection button in until it stops. Continue holding in the injection button while slowly counting to 5 to get a full dose.</item>
                                 <item>
                                    <caption>â¢</caption>Remove needle from skin.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Injection is complete when the <renderMultiMedia ID="id-707955226" referencedObject="D16A43A6-B241-45D9-A49C-B865AAF85744"/> is in the center of the dose window.</item>
                                 <item>
                                    <caption>â¢</caption>The pen is now ready to reset.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you see several drops of BYETTA leaking from the needle after the injection, you may not have received a complete dose. See <content styleCode="bold">Commonly Asked Questions, </content>number 4, in Section 4 of these Instructions for Use.</paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 5 Reset the Pen</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="3" valign="top">
                              <renderMultiMedia ID="id1084800275" referencedObject="ID_55fa0bf7-1156-4905-861d-ada58ddf4bb5"/>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Turn dose knob away from you until it stops</content> and the <renderMultiMedia ID="id-131800237" referencedObject="EA60FBE3-E941-4279-B44A-B5FC19DE1F6B"/> is in the dose window.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">Note:</content> If you cannot turn the dose knob, or if your pen leaks, your full dose has not been delivered. See <content styleCode="bold">Commonly Asked Questions,</content> numbers 4 and 7, in Section 4 of these Instructions for Use.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 6 Remove and Dispose of the Needle</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top"/>
                        </tr>
                        <tr>
                           <td align="center" colspan="3" valign="top">
                              <renderMultiMedia ID="id1419135841" referencedObject="C450F79C-07AC-48E9-A95F-1982734F72BD"/>
                           </td>
                           <td align="center" colspan="2" valign="top">
                              <renderMultiMedia ID="id279465182" referencedObject="B9110BD8-8845-4C72-BF96-079AFCAC3036"/>
                           </td>
                           <td align="center" valign="top">
                              <renderMultiMedia ID="id1106233198" referencedObject="F6E1B4A5-5B33-487B-A22A-24721B065488"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Carefully put the outer needle shield back over the needle.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">Remove the needle after each injection.</content>
                                 </item>
                              </list>
                           </td>
                           <td colspan="2" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Unscrew the needle.</item>
                              </list>
                           </td>
                           <td valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Throw away needles in a FDA-cleared sharps disposal container (See above âHow do I throw needles?â) or as recommended by your healthcare provider.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">STEP 7 Store Pen for Next Dose</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Replace Blue Pen Cap on pen before storage.</item>
                                 <item>
                                    <caption>â¢</caption>Store your BYETTA Pen at a temperature between 36Â°F to 77Â°F (2Â°C to 25Â°C). (See<content styleCode="bold"> Storing Your BYETTA Pen</content> in Section 1 of these Instructions for Use for complete storage information.)</item>
                                 <item>
                                    <caption>â¢</caption>When it is time for your next routine dose, go to <content styleCode="bold">Section 3, Step 1,</content> and repeat Steps 1â7.</item>
                              </list>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Section 4</content>
                              </paragraph>
                           </td>
                           <td colspan="4" valign="top">
                              <paragraph>
                                 <content styleCode="bold">COMMONLY ASKED QUESTIONS</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">1.</content>
                              </paragraph>
                           </td>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Do I need to do the One-Time-Only New Pen Setup before every dose?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>No. <content styleCode="bold">The One-Time-Only New Pen Setup is done only once, just before each new pen is used for the first time.</content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>The purpose of the setup is to make sure that your BYETTA Pen is ready to use for the next 30 days.</item>
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">If you repeat the One-Time-Only New Pen Setup before each routine dose, you will not have enough BYETTA for 30 days.</content> The small amount of BYETTA used in the new pen setup will not affect the 30-day supply of BYETTA.</item>
                              </list>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">2. </content>
                              </paragraph>
                           </td>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Why are there air bubbles in the cartridge?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>A small air bubble is normal. It will not harm you or affect your dose.</item>
                                 <item>
                                    <caption>â¢</caption>If the pen is stored with a needle attached, air bubbles may form in the cartridge. <content styleCode="bold">Do not</content> store the pen with the needle attached.</item>
                              </list>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">3.</content>
                              </paragraph>
                           </td>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">What should I do if BYETTA does not come out of the needle tip after four tries during One-Time-Only New Pen Setup?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Carefully put the outer needle shield back over the needle. Remove the needle by unscrewing it. Throw away the needle properly.</item>
                                 <item>
                                    <caption>â¢</caption>Attach a new needle and repeat <content styleCode="bold">One-Time-Only New Pen Setup, Steps BâE,</content> in Section 2 of these Instructions for Use. Once you see several drops or a stream of liquid coming out of the tip of the needle, the setup is complete.</item>
                              </list>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td rowspan="2" valign="top">
                              <paragraph>
                                 <content styleCode="bold">4.</content>
                              </paragraph>
                           </td>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Why do I see BYETTA leaking from my needle after I have finished my injection?</content>
                              </paragraph>
                              <paragraph>Â <br/>It is normal for a single drop to remain on the tip of your needle after your injection is complete. If you see more than one drop:</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="5" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>You may not have received your full dose. <content styleCode="bold">Do not inject another dose.</content> Talk with your healthcare provider about what to do about a partial dose.</item>
                                 <item>
                                    <caption>â¢</caption>To make sure that you get your full dose, when you take your injections, <content styleCode="bold">firmly push and hold</content> the injection button in and <content styleCode="bold">slowly count to 5</content> (see <content styleCode="bold">Section 3, Step 4: Inject the Dose</content>).</item>
                              </list>
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">5.</content>
                              </paragraph>
                           </td>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">How can I tell when the injection is complete?</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <paragraph>Â </paragraph>
                              <paragraph>The injection is complete when:</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>You have firmly pushed the injection button in all the way <content styleCode="bold">until it stops</content>
                                 </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td align="center" colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">and</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>
                                    <content styleCode="bold">You have slowly counted to 5</content> while you are still holding the injection button in and the needle is still in your skin</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td align="center" colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">and</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>The <renderMultiMedia ID="id916066539" referencedObject="ID_1b2f3416-e4a7-4465-bed7-93a02eaa8bb0"/> is in the center of the dose window.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <paragraph>Â </paragraph>
                              <paragraph>If you hear a click sound from your BYETTA Pen, ignore it. You must follow all the steps listed above to make sure your injection is complete.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">6.</content>
                              </paragraph>
                           </td>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Where should I inject BYETTA?</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="3" valign="top">
                              <paragraph>Inject BYETTA into your abdomen, thigh, or upper arm using the injection method explained to you by your healthcare provider.</paragraph>
                              <paragraph>Change (rotate) your injection sites within the area you choose for each dose.Â <content styleCode="bold">Do not</content>Â use the same injection site for each injection.</paragraph>
                              <paragraph>Â </paragraph>
                           </td>
                           <td colspan="2" valign="top">
                              <renderMultiMedia ID="id1498529089" referencedObject="ED93F7D6-B735-4F6A-9E29-95F13AC0240D"/>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top">
                              <paragraph>
                                 <content styleCode="bold">7.</content>
                              </paragraph>
                           </td>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">What if I cannot pull, turn, or push the dose knob?</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <paragraph>Check the symbol in the dose window. Follow the steps next to the matching symbol.</paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>
                                 <content styleCode="bold">If </content>
                                 <renderMultiMedia ID="id-752892297" referencedObject="ID_8479d1b6-c223-47b3-9c7d-188ad9971216"/>
                                 <content styleCode="bold"> is in the dose window:</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>Pull the dose knob out until <renderMultiMedia ID="id1013655045" referencedObject="ID_270364e0-47dc-4bc8-85ad-ac1f0d4ad109"/> appears.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">If </content>
                                 <renderMultiMedia ID="id-676421741" referencedObject="ID_71027bd0-a998-4569-ae76-c18ed2b90572"/>
                                 <content styleCode="bold"> is in the dose window and the dose knob will not turn:</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>The cartridge in your BYETTA Pen may not have enough medicine to deliver a full dose. A small amount of BYETTA will always stay in the cartridge. If the cartridge contains a small amount and the dose knob will not turn, your pen does not have enough BYETTA and will not deliver any more doses. Obtain a new BYETTA Pen.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â If </content>
                                 <renderMultiMedia ID="id651488429" referencedObject="ID_80decade-a676-4cca-b72f-727d66cba93b"/>
                                 <content styleCode="bold"> and part of </content>
                                 <renderMultiMedia ID="id337356407" referencedObject="AEBE0D6B-0AEA-4ADA-92DF-18C88EBEB5BE"/>
                                 <content styleCode="bold"> are in the dose window and the dose knob cannot be pushed in:</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>The dose knob was not turned all the way. Continue turning the dose knob away from you until <renderMultiMedia ID="id-1884157704" referencedObject="B76410DE-3B48-43D4-A16D-648559EF2CDE"/> is in the center of the dose window.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">If part of </content>
                                 <renderMultiMedia ID="id1529983236" referencedObject="ID_9118d122-1521-4c7a-a27d-ca4bbadf4ebb"/>
                                 <content styleCode="bold">and part of </content>
                                 <renderMultiMedia ID="id1480181713" referencedObject="DD9B2886-4667-4CA6-B08E-7FABC199D7F3"/>
                                 <content styleCode="bold"> are in the dose window and the dose knob cannot be pushed in: </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>The needle may be clogged, bent, or incorrectly attached.</item>
                                 <item>
                                    <caption>â¢</caption>Attach a new needle. Make sure needle is on straight and screwed on all the way.</item>
                                 <item>
                                    <caption>â¢</caption>Firmly push the injection button in all the way. BYETTA should come from needle tip.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <paragraph>
                                 <content styleCode="bold">If </content>
                                 <renderMultiMedia ID="id31931947" referencedObject="ID_700a8c3d-a8dd-45fb-9597-583332939513"/>
                                 <content styleCode="bold"> is in the dose window and the dose knob will not turn: </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>The injection button was not pushed in all the way and a complete dose was not delivered. <content styleCode="bold">Talk with your healthcare provider about what to do about a partial dose. </content>
                                 </item>
                                 <item>
                                    <caption>â¢</caption>Follow these steps to reset your pen for your next injection:<list listType="unordered">
                                       <item>
                                          <caption>â</caption>Firmly push the injection button in all the way <content styleCode="bold">until it stops</content>. Keep holding the injection button in and <content styleCode="bold">slowly count to 5</content>. Then release the injection button and turn the dose knob away from you until <renderMultiMedia ID="id1966080960" referencedObject="F2A5DBB4-F5AA-4072-83C5-4DA3F7578CC9"/>  appears in the dose window.</item>
                                       <item>
                                          <caption>â</caption>If you cannot turn the dose knob, the needle may be clogged. Replace the needle and repeat the step above.</item>
                                    </list>
                                 </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td valign="top"/>
                           <td colspan="5" valign="top">
                              <list listType="unordered">
                                 <item>
                                    <caption>â¢</caption>For your next dose, be sure to <content styleCode="bold">firmly push and hold</content> the injection button in and <content styleCode="bold">slowly count to 5</content> before removing needle from skin.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>Â </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="6" valign="top">
                              <paragraph>
                                 <content styleCode="bold">See the complete BYETTA Medication Guide that comes with BYETTA. For more information, call toll free 1-800-236-9933.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Â </content>
                              </paragraph>
                              <paragraph>Distributed by:<br/>AstraZeneca Pharmaceuticals LP<br/>Wilmington, DE 19850 </paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>Â </paragraph>
                              <paragraph>BYETTA<sup>Â®</sup> is a registered trademark of the AstraZeneca group of companies.</paragraph>
                              <paragraph>This Instructions for Use has been approved by the U.S. Food and Drug Administration</paragraph>
                              <paragraph>Revised: May 2025</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20250528"/>
               <component>
                  <observationMedia ID="ID_6356dd5a-bda1-470f-8241-194494c91ec8">
                     <text>Byetta 10mcg Pen</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-12.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_356b96cf-7b0d-40ae-b3be-b3d576899e8b">
                     <text>penparts</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-13.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_03400a55-02cc-4d84-89d6-d0a6d3fa8273">
                     <text>Pen needle parts</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-14.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="D7AEE561-A2E2-431D-8423-3FE6162F076B">
                     <text>Figure</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-15.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_77619733-a559-40b4-aa61-7cee9346cf3a">
                     <text>Figure</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-16.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_38e79ef6-6911-4555-884e-cb7538c09d84">
                     <text>Remove paper</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-17.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="A4802CAF-DAEE-4005-BA50-DA8532E344CE">
                     <text>Pull off outer</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-18.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_04137db8-04ac-474e-aa5f-fbd404e2aa71">
                     <text>Pull off inner</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-19.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_83a42af8-d599-41ba-94a7-7f2c366e6b7c">
                     <text>Check arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-20.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_75cc9339-66ce-4903-aeee-26d055f8ec88">
                     <text>Pull dose knob out</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-21.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_71462db2-3c12-4858-9325-098caba2867c">
                     <text>Turn dose knob</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-22.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_53381eed-f380-4173-a42c-a3571f5ada02">
                     <text>right facing arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-23.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="E268FABA-BCD3-4911-99A9-8898888C0347">
                     <text>right facing arrows</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-24.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_53dae1d8-388c-46b9-a4bb-cfdc280aecf3">
                     <text>up facing arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-25.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="AAF3F374-B4E7-421E-98DF-2EAC75005445">
                     <text>10</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-26.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_335a7a54-6637-436a-a7b4-e3d30bbbbc50">
                     <text>10</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-27.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_9c698999-16c7-48f6-b1d5-513779faeab4">
                     <text>Point needle</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-28.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_56ffa3d3-5038-4dfe-891f-6cfbcaed3828">
                     <text>Push and Hold</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-29.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="AAF4B944-8DB6-4022-9493-BE8CD3825E0B">
                     <text>Figure</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-30.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_6536d366-c206-48a9-9f35-b67bf78bb48a">
                     <text>triangle3</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-31.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_5344c52d-37d5-44ed-b2e0-0508e68674cf">
                     <text>Turn knob away</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-32.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_5d611962-5536-4d14-8933-583858338b3c">
                     <text>right arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-33.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_2cde2c36-d84d-4cde-ad45-f0eea9b958d4">
                     <text>Check Pen label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-34.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_062d12ee-dc62-4206-85d1-b7d1128ee1d4">
                     <text>Check cartridge</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-35.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_112a4d08-27d1-4780-a7ef-e66099d66f18">
                     <text>Remove paper tab</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-36.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_901ec7bf-8cfc-4a0a-b479-a9e5044a2206">
                     <text>Pull off outer needle</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-37.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_7b8daf75-04ad-478e-a7af-734880d0fc0c">
                     <text>Pull off inner needle</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-38.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_9a473891-4c8d-4c6f-b02d-7d4b8c72d5d0">
                     <text>Arrow dose</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-39.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_5fd59447-318e-477b-9946-df7867d5853b">
                     <text>Pull knob unti it stops</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-40.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="D946F68F-5DA2-46F0-B215-0A122751335F">
                     <text>Turn dose know away from you</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-42.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="A9748551-52BC-4476-BFE0-54F0078162B9">
                     <text>right arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-43.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_084d3851-7959-4252-8f78-bb37715f479f">
                     <text>right arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-44.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="BE4AD158-35F0-4FBA-AFA7-16E3C7D5F22C">
                     <text>uparrow1</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-45.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="A4C61307-7ACE-4CFD-BCCB-7CFDF96C3AD8">
                     <text>10</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-46.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_9ec894ac-9ab1-4de1-97e3-77cc08320af1">
                     <text>10</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-47.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="CA8E0064-4A49-4823-B749-DA1EA49E8B63">
                     <text>Grip pen</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-48.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_2d3b5be3-80c1-46f5-987e-85f9ee4eece1">
                     <text>Push injection</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-49.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_61de1d24-ed49-49bc-a03c-531245134c65">
                     <text>Injection complete</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-50.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="D16A43A6-B241-45D9-A49C-B865AAF85744">
                     <text>triangle5</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-55.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_55fa0bf7-1156-4905-861d-ada58ddf4bb5">
                     <text>Turn knob away until it stops</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-57.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="EA60FBE3-E941-4279-B44A-B5FC19DE1F6B">
                     <text>right arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-58.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="C450F79C-07AC-48E9-A95F-1982734F72BD">
                     <text>Cover needle</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-59.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="B9110BD8-8845-4C72-BF96-079AFCAC3036">
                     <text>Unscrew</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-60.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="F6E1B4A5-5B33-487B-A22A-24721B065488">
                     <text>Throw away needle</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-61.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_1b2f3416-e4a7-4465-bed7-93a02eaa8bb0">
                     <text>triangle4</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-62.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ED93F7D6-B735-4F6A-9E29-95F13AC0240D">
                     <text>Where to inject Byetta</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-63.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_8479d1b6-c223-47b3-9c7d-188ad9971216">
                     <text>rightarrow2</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-64.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_270364e0-47dc-4bc8-85ad-ac1f0d4ad109">
                     <text>plus sign</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-65.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_71027bd0-a998-4569-ae76-c18ed2b90572">
                     <text>plus sign</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-66.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_80decade-a676-4cca-b72f-727d66cba93b">
                     <text>pushed in arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-67.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="AEBE0D6B-0AEA-4ADA-92DF-18C88EBEB5BE">
                     <text>10</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-68.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="B76410DE-3B48-43D4-A16D-648559EF2CDE">
                     <text>10</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-69.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_9118d122-1521-4c7a-a27d-ca4bbadf4ebb">
                     <text>10</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-70.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="DD9B2886-4667-4CA6-B08E-7FABC199D7F3">
                     <text>up arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-71.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_700a8c3d-a8dd-45fb-9597-583332939513">
                     <text>up arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-72.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="F2A5DBB4-F5AA-4072-83C5-4DA3F7578CC9">
                     <text>Rarrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Rarrow.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="PDP1">
               <id root="a03fe99a-b0cb-47e4-b59c-b641d29a052a"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>Package/Label Display Panel â 5 mcg</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">5 mcg per dose</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 0310-6512-01</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Byetta<sup>Â®</sup> exenatide injection</content>
                  </paragraph>
                  <paragraph>250 mcg/mL, 1.2 mL</paragraph>
                  <paragraph>
                     <content styleCode="bold">Dispense the enclosed Medication Guide to each patient</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">For Single Patient Use Only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Each prefilled pen will deliver 60 subcutaneous doses, 5 mcg per dose</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">SUBCUTANEOUS USE ONLY</content>
                     <br/>
                     <content styleCode="bold">REFRIGERATE â DO NOT FREEZE</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">DO NOT TRANSFER THIS MEDICATION TO A SYRINGE</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Pen needles not included</content>
                  </paragraph>
                  <paragraph>Ask your healthcare provider which pen needle length and gauge is best for you<br/>Use 29 (thin), 30, or 31 (thinner) gauge disposable pen needles</paragraph>
                  <paragraph>
                     <content styleCode="bold">AstraZeneca</content>
                  </paragraph>
                  <renderMultiMedia ID="id1537058350" referencedObject="ID_38a27a5a-314f-4238-af8c-94e6509d978d"/>
               </text>
               <effectiveTime value="20221221"/>
               <component>
                  <observationMedia ID="ID_38a27a5a-314f-4238-af8c-94e6509d978d">
                     <text>5mcg</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_5829d666-3a8e-4bc5-83f5-c66d9640e8e4">
               <id root="b4fba384-7425-4f78-95ce-d7913b619f81"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>Package/Label Display Panel â 10 mcg</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">10 mcg per dose</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 0310-6524-01</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Byetta<sup>Â®</sup> exenatide injection</content>
                  </paragraph>
                  <paragraph>250 mcg/mL, 2.4 mL</paragraph>
                  <paragraph>
                     <content styleCode="bold">Dispense the enclosed Medication Guide to each patient</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">For Single Patient Use Only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Each prefilled pen will deliver 60 subcutaneous doses, 10 mcg per dose</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">SUBCUTANEOUS USE ONLY</content>
                     <br/>
                     <content styleCode="bold">REFRIGERATE â DO NOT FREEZE</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">DO NOT TRANSFER THIS MEDICATION TO A SYRINGE</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Pen needles not included</content>
                  </paragraph>
                  <paragraph>Ask your healthcare provider which pen needle length and gauge is best for you<br/>Use 29 (thin), 30, or 31 (thinner) gauge disposable pen needles</paragraph>
                  <paragraph>
                     <content styleCode="bold">AstraZeneca</content>
                  </paragraph>
                  <renderMultiMedia ID="id4292" referencedObject="b9de796f-cccb-4270-a33f-284b73deddb2"/>
               </text>
               <effectiveTime value="20241101"/>
               <component>
                  <observationMedia ID="b9de796f-cccb-4270-a33f-284b73deddb2">
                     <text>10mcg</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="byetta-70.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>